<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for EP 1489395374806 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_COLON_CANCER_MSI_VS_MSS_DN'>WATANABE_COLON_CANCER_MSI_VS_MSS_DN</a></td><td><a href='WATANABE_COLON_CANCER_MSI_VS_MSS_DN.html'>Details ...</a></td><td>46</td><td>-0.50</td><td>-1.86</td><td>0.000</td><td>1.000</td><td>0.510</td><td>2188</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_TOP50_UP'>CHANDRAN_METASTASIS_TOP50_UP</a></td><td><a href='CHANDRAN_METASTASIS_TOP50_UP.html'>Details ...</a></td><td>20</td><td>-0.57</td><td>-1.76</td><td>0.000</td><td>1.000</td><td>0.860</td><td>992</td><td>tags=45%, list=9%, signal=49%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_PML_INTERACTOME'>WIERENGA_PML_INTERACTOME</a></td><td><a href='WIERENGA_PML_INTERACTOME.html'>Details ...</a></td><td>19</td><td>-0.66</td><td>-1.73</td><td>0.000</td><td>1.000</td><td>0.920</td><td>2201</td><td>tags=53%, list=20%, signal=66%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP'>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</a></td><td><a href='OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP.html'>Details ...</a></td><td>29</td><td>-0.52</td><td>-1.71</td><td>0.000</td><td>1.000</td><td>0.960</td><td>2082</td><td>tags=48%, list=19%, signal=60%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6'>MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6</a></td><td><a href='MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6.html'>Details ...</a></td><td>26</td><td>-0.58</td><td>-1.68</td><td>0.000</td><td>1.000</td><td>0.970</td><td>2026</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LIAO_HAVE_SOX4_BINDING_SITES'>LIAO_HAVE_SOX4_BINDING_SITES</a></td><td><a href='LIAO_HAVE_SOX4_BINDING_SITES.html'>Details ...</a></td><td>22</td><td>-0.55</td><td>-1.66</td><td>0.021</td><td>1.000</td><td>0.990</td><td>1017</td><td>tags=45%, list=9%, signal=50%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/EPPERT_LSC_R'>EPPERT_LSC_R</a></td><td><a href='EPPERT_LSC_R.html'>Details ...</a></td><td>25</td><td>-0.63</td><td>-1.62</td><td>0.020</td><td>1.000</td><td>0.990</td><td>2036</td><td>tags=52%, list=19%, signal=64%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/JI_RESPONSE_TO_FSH_UP'>JI_RESPONSE_TO_FSH_UP</a></td><td><a href='JI_RESPONSE_TO_FSH_UP.html'>Details ...</a></td><td>44</td><td>-0.42</td><td>-1.61</td><td>0.021</td><td>1.000</td><td>1.000</td><td>2036</td><td>tags=45%, list=19%, signal=56%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_6HR'>RIZ_ERYTHROID_DIFFERENTIATION_6HR</a></td><td><a href='RIZ_ERYTHROID_DIFFERENTIATION_6HR.html'>Details ...</a></td><td>21</td><td>-0.60</td><td>-1.60</td><td>0.022</td><td>1.000</td><td>1.000</td><td>2832</td><td>tags=62%, list=26%, signal=84%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP'>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</a></td><td><a href='GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP.html'>Details ...</a></td><td>48</td><td>-0.47</td><td>-1.60</td><td>0.042</td><td>1.000</td><td>1.000</td><td>1960</td><td>tags=48%, list=18%, signal=58%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_AUTOCRINE_TARGETS_DN'>XU_GH1_AUTOCRINE_TARGETS_DN</a></td><td><a href='XU_GH1_AUTOCRINE_TARGETS_DN.html'>Details ...</a></td><td>76</td><td>-0.42</td><td>-1.60</td><td>0.000</td><td>1.000</td><td>1.000</td><td>3145</td><td>tags=58%, list=29%, signal=81%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/THUM_SYSTOLIC_HEART_FAILURE_DN'>THUM_SYSTOLIC_HEART_FAILURE_DN</a></td><td><a href='THUM_SYSTOLIC_HEART_FAILURE_DN.html'>Details ...</a></td><td>132</td><td>-0.42</td><td>-1.60</td><td>0.043</td><td>1.000</td><td>1.000</td><td>1904</td><td>tags=39%, list=17%, signal=46%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN'>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</a></td><td><a href='SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN.html'>Details ...</a></td><td>18</td><td>-0.62</td><td>-1.59</td><td>0.022</td><td>1.000</td><td>1.000</td><td>2170</td><td>tags=67%, list=20%, signal=83%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_18HR_UP'>BROWNE_HCMV_INFECTION_18HR_UP</a></td><td><a href='BROWNE_HCMV_INFECTION_18HR_UP.html'>Details ...</a></td><td>99</td><td>-0.41</td><td>-1.59</td><td>0.021</td><td>1.000</td><td>1.000</td><td>1744</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_UP'>SANSOM_APC_TARGETS_UP</a></td><td><a href='SANSOM_APC_TARGETS_UP.html'>Details ...</a></td><td>69</td><td>-0.40</td><td>-1.59</td><td>0.000</td><td>1.000</td><td>1.000</td><td>2253</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHOI_ATL_STAGE_PREDICTOR'>CHOI_ATL_STAGE_PREDICTOR</a></td><td><a href='CHOI_ATL_STAGE_PREDICTOR.html'>Details ...</a></td><td>24</td><td>-0.48</td><td>-1.58</td><td>0.021</td><td>1.000</td><td>1.000</td><td>1758</td><td>tags=46%, list=16%, signal=55%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S'>WHITFIELD_CELL_CYCLE_G1_S</a></td><td><a href='WHITFIELD_CELL_CYCLE_G1_S.html'>Details ...</a></td><td>70</td><td>-0.46</td><td>-1.58</td><td>0.021</td><td>1.000</td><td>1.000</td><td>2800</td><td>tags=49%, list=26%, signal=65%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_VIA_TSC2'>BILANGES_SERUM_SENSITIVE_VIA_TSC2</a></td><td><a href='BILANGES_SERUM_SENSITIVE_VIA_TSC2.html'>Details ...</a></td><td>18</td><td>-0.57</td><td>-1.58</td><td>0.000</td><td>1.000</td><td>1.000</td><td>2131</td><td>tags=67%, list=20%, signal=83%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_LIVER_DEVELOPMENT_UP'>CAIRO_LIVER_DEVELOPMENT_UP</a></td><td><a href='CAIRO_LIVER_DEVELOPMENT_UP.html'>Details ...</a></td><td>86</td><td>-0.42</td><td>-1.57</td><td>0.043</td><td>1.000</td><td>1.000</td><td>3199</td><td>tags=56%, list=29%, signal=78%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_UP'>PROVENZANI_METASTASIS_UP</a></td><td><a href='PROVENZANI_METASTASIS_UP.html'>Details ...</a></td><td>91</td><td>-0.38</td><td>-1.57</td><td>0.000</td><td>1.000</td><td>1.000</td><td>1353</td><td>tags=32%, list=12%, signal=36%</td></tr><tr><td class='lessen'>21</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN</td><td></td><td>44</td><td>-0.43</td><td>-1.57</td><td>0.000</td><td>1.000</td><td>1.000</td><td>1108</td><td>tags=34%, list=10%, signal=38%</td></tr><tr><td class='lessen'>22</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN</td><td></td><td>18</td><td>-0.53</td><td>-1.56</td><td>0.040</td><td>1.000</td><td>1.000</td><td>1877</td><td>tags=56%, list=17%, signal=67%</td></tr><tr><td class='lessen'>23</td><td>VANTVEER_BREAST_CANCER_BRCA1_UP</td><td></td><td>17</td><td>-0.56</td><td>-1.56</td><td>0.060</td><td>1.000</td><td>1.000</td><td>1257</td><td>tags=35%, list=12%, signal=40%</td></tr><tr><td class='lessen'>24</td><td>RODRIGUES_THYROID_CARCINOMA_DN</td><td></td><td>50</td><td>-0.47</td><td>-1.56</td><td>0.000</td><td>1.000</td><td>1.000</td><td>1740</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>25</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</td><td></td><td>344</td><td>-0.41</td><td>-1.55</td><td>0.043</td><td>1.000</td><td>1.000</td><td>2034</td><td>tags=38%, list=19%, signal=45%</td></tr><tr><td class='lessen'>26</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td><td></td><td>25</td><td>-0.49</td><td>-1.55</td><td>0.022</td><td>0.982</td><td>1.000</td><td>1860</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>27</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>64</td><td>-0.46</td><td>-1.54</td><td>0.037</td><td>1.000</td><td>1.000</td><td>3312</td><td>tags=59%, list=30%, signal=85%</td></tr><tr><td class='lessen'>28</td><td>LEE_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>82</td><td>-0.48</td><td>-1.53</td><td>0.043</td><td>1.000</td><td>1.000</td><td>2590</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>29</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN</td><td></td><td>36</td><td>-0.43</td><td>-1.53</td><td>0.000</td><td>1.000</td><td>1.000</td><td>852</td><td>tags=33%, list=8%, signal=36%</td></tr><tr><td class='lessen'>30</td><td>BLUM_RESPONSE_TO_SALIRASIB_DN</td><td></td><td>170</td><td>-0.50</td><td>-1.52</td><td>0.023</td><td>1.000</td><td>1.000</td><td>2336</td><td>tags=48%, list=21%, signal=60%</td></tr><tr><td class='lessen'>31</td><td>RHODES_CANCER_META_SIGNATURE</td><td></td><td>29</td><td>-0.56</td><td>-1.52</td><td>0.058</td><td>0.999</td><td>1.000</td><td>2257</td><td>tags=62%, list=21%, signal=78%</td></tr><tr><td class='lessen'>32</td><td>AIGNER_ZEB1_TARGETS</td><td></td><td>15</td><td>-0.70</td><td>-1.52</td><td>0.089</td><td>0.986</td><td>1.000</td><td>2958</td><td>tags=87%, list=27%, signal=119%</td></tr><tr><td class='lessen'>33</td><td>MUELLER_PLURINET</td><td></td><td>144</td><td>-0.46</td><td>-1.52</td><td>0.023</td><td>0.977</td><td>1.000</td><td>2359</td><td>tags=47%, list=22%, signal=59%</td></tr><tr><td class='lessen'>34</td><td>PAL_PRMT5_TARGETS_UP</td><td></td><td>99</td><td>-0.48</td><td>-1.52</td><td>0.040</td><td>0.948</td><td>1.000</td><td>1364</td><td>tags=36%, list=13%, signal=41%</td></tr><tr><td class='lessen'>35</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP</td><td></td><td>29</td><td>-0.49</td><td>-1.52</td><td>0.038</td><td>0.927</td><td>1.000</td><td>2811</td><td>tags=55%, list=26%, signal=74%</td></tr><tr><td class='lessen'>36</td><td>SONG_TARGETS_OF_IE86_CMV_PROTEIN</td><td></td><td>31</td><td>-0.57</td><td>-1.51</td><td>0.070</td><td>0.922</td><td>1.000</td><td>2010</td><td>tags=55%, list=18%, signal=67%</td></tr><tr><td class='lessen'>37</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>115</td><td>-0.46</td><td>-1.51</td><td>0.096</td><td>0.900</td><td>1.000</td><td>2638</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>38</td><td>ABRAMSON_INTERACT_WITH_AIRE</td><td></td><td>27</td><td>-0.67</td><td>-1.51</td><td>0.063</td><td>0.882</td><td>1.000</td><td>2217</td><td>tags=63%, list=20%, signal=79%</td></tr><tr><td class='lessen'>39</td><td>WHITFIELD_CELL_CYCLE_M_G1</td><td></td><td>76</td><td>-0.38</td><td>-1.51</td><td>0.020</td><td>0.865</td><td>1.000</td><td>1050</td><td>tags=26%, list=10%, signal=29%</td></tr><tr><td class='lessen'>40</td><td>DAWSON_METHYLATED_IN_LYMPHOMA_TCL1</td><td></td><td>27</td><td>-0.46</td><td>-1.50</td><td>0.038</td><td>0.893</td><td>1.000</td><td>1990</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>41</td><td>LIN_MELANOMA_COPY_NUMBER_UP</td><td></td><td>39</td><td>-0.40</td><td>-1.50</td><td>0.038</td><td>0.915</td><td>1.000</td><td>2561</td><td>tags=38%, list=24%, signal=50%</td></tr><tr><td class='lessen'>42</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>61</td><td>-0.41</td><td>-1.49</td><td>0.019</td><td>0.911</td><td>1.000</td><td>2082</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>43</td><td>STANELLE_E2F1_TARGETS</td><td></td><td>15</td><td>-0.56</td><td>-1.49</td><td>0.024</td><td>0.900</td><td>1.000</td><td>2663</td><td>tags=53%, list=24%, signal=71%</td></tr><tr><td class='lessen'>44</td><td>BHATTACHARYA_EMBRYONIC_STEM_CELL</td><td></td><td>47</td><td>-0.53</td><td>-1.47</td><td>0.071</td><td>0.985</td><td>1.000</td><td>1494</td><td>tags=47%, list=14%, signal=54%</td></tr><tr><td class='lessen'>45</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN</td><td></td><td>79</td><td>-0.56</td><td>-1.47</td><td>0.119</td><td>0.964</td><td>1.000</td><td>2648</td><td>tags=58%, list=24%, signal=76%</td></tr><tr><td class='lessen'>46</td><td>HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC</td><td></td><td>24</td><td>-0.45</td><td>-1.47</td><td>0.019</td><td>0.962</td><td>1.000</td><td>1714</td><td>tags=42%, list=16%, signal=49%</td></tr><tr><td class='lessen'>47</td><td>JIANG_HYPOXIA_VIA_VHL</td><td></td><td>17</td><td>-0.47</td><td>-1.47</td><td>0.045</td><td>0.944</td><td>1.000</td><td>1798</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>48</td><td>HEIDENBLAD_AMPLICON_8Q24_DN</td><td></td><td>21</td><td>-0.42</td><td>-1.47</td><td>0.047</td><td>0.955</td><td>1.000</td><td>2461</td><td>tags=43%, list=23%, signal=55%</td></tr><tr><td class='lessen'>49</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN</td><td></td><td>15</td><td>-0.58</td><td>-1.47</td><td>0.021</td><td>0.937</td><td>1.000</td><td>2933</td><td>tags=60%, list=27%, signal=82%</td></tr><tr><td class='lessen'>50</td><td>BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN</td><td></td><td>32</td><td>-0.49</td><td>-1.46</td><td>0.045</td><td>0.956</td><td>1.000</td><td>1332</td><td>tags=31%, list=12%, signal=36%</td></tr><tr><td class='lessen'>51</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>262</td><td>-0.35</td><td>-1.46</td><td>0.022</td><td>0.944</td><td>1.000</td><td>2054</td><td>tags=34%, list=19%, signal=41%</td></tr><tr><td class='lessen'>52</td><td>LANG_MYB_FAMILY_TARGETS</td><td></td><td>23</td><td>-0.46</td><td>-1.46</td><td>0.063</td><td>0.932</td><td>1.000</td><td>1419</td><td>tags=39%, list=13%, signal=45%</td></tr><tr><td class='lessen'>53</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN</td><td></td><td>16</td><td>-0.51</td><td>-1.45</td><td>0.098</td><td>0.934</td><td>1.000</td><td>1129</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>54</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14</td><td></td><td>70</td><td>-0.39</td><td>-1.45</td><td>0.107</td><td>0.948</td><td>1.000</td><td>2621</td><td>tags=46%, list=24%, signal=60%</td></tr><tr><td class='lessen'>55</td><td>SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS</td><td></td><td>25</td><td>-0.44</td><td>-1.45</td><td>0.021</td><td>0.937</td><td>1.000</td><td>2627</td><td>tags=56%, list=24%, signal=74%</td></tr><tr><td class='lessen'>56</td><td>SANSOM_WNT_PATHWAY_REQUIRE_MYC</td><td></td><td>34</td><td>-0.44</td><td>-1.45</td><td>0.064</td><td>0.926</td><td>1.000</td><td>2289</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>57</td><td>CARD_MIR302A_TARGETS</td><td></td><td>39</td><td>-0.39</td><td>-1.44</td><td>0.073</td><td>0.917</td><td>1.000</td><td>809</td><td>tags=23%, list=7%, signal=25%</td></tr><tr><td class='lessen'>58</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>55</td><td>-0.46</td><td>-1.44</td><td>0.135</td><td>0.912</td><td>1.000</td><td>1643</td><td>tags=42%, list=15%, signal=49%</td></tr><tr><td class='lessen'>59</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>68</td><td>-0.35</td><td>-1.44</td><td>0.021</td><td>0.906</td><td>1.000</td><td>1397</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>60</td><td>SU_TESTIS</td><td></td><td>50</td><td>-0.43</td><td>-1.44</td><td>0.087</td><td>0.901</td><td>1.000</td><td>2156</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>61</td><td>YAGI_AML_SURVIVAL</td><td></td><td>60</td><td>-0.35</td><td>-1.44</td><td>0.000</td><td>0.890</td><td>1.000</td><td>1947</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>62</td><td>BENPORATH_ES_1</td><td></td><td>176</td><td>-0.37</td><td>-1.43</td><td>0.149</td><td>0.926</td><td>1.000</td><td>2926</td><td>tags=49%, list=27%, signal=67%</td></tr><tr><td class='lessen'>63</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>31</td><td>-0.44</td><td>-1.43</td><td>0.040</td><td>0.920</td><td>1.000</td><td>2226</td><td>tags=45%, list=20%, signal=57%</td></tr><tr><td class='lessen'>64</td><td>TANG_SENESCENCE_TP53_TARGETS_DN</td><td></td><td>27</td><td>-0.56</td><td>-1.43</td><td>0.239</td><td>0.907</td><td>1.000</td><td>2857</td><td>tags=67%, list=26%, signal=90%</td></tr><tr><td class='lessen'>65</td><td>RODRIGUES_NTN1_AND_DCC_TARGETS</td><td></td><td>24</td><td>-0.49</td><td>-1.43</td><td>0.082</td><td>0.906</td><td>1.000</td><td>1354</td><td>tags=38%, list=12%, signal=43%</td></tr><tr><td class='lessen'>66</td><td>CROONQUIST_NRAS_SIGNALING_DN</td><td></td><td>44</td><td>-0.55</td><td>-1.43</td><td>0.214</td><td>0.899</td><td>1.000</td><td>2559</td><td>tags=61%, list=24%, signal=80%</td></tr><tr><td class='lessen'>67</td><td>ZHAN_MULTIPLE_MYELOMA_PR_UP</td><td></td><td>27</td><td>-0.66</td><td>-1.42</td><td>0.267</td><td>0.894</td><td>1.000</td><td>2027</td><td>tags=67%, list=19%, signal=82%</td></tr><tr><td class='lessen'>68</td><td>RIZ_ERYTHROID_DIFFERENTIATION_CCNE1</td><td></td><td>21</td><td>-0.46</td><td>-1.42</td><td>0.020</td><td>0.892</td><td>1.000</td><td>1176</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>69</td><td>GRADE_COLON_CANCER_DN</td><td></td><td>17</td><td>-0.53</td><td>-1.42</td><td>0.039</td><td>0.887</td><td>1.000</td><td>3136</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>70</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP</td><td></td><td>26</td><td>-0.44</td><td>-1.41</td><td>0.104</td><td>0.909</td><td>1.000</td><td>2464</td><td>tags=58%, list=23%, signal=74%</td></tr><tr><td class='lessen'>71</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>225</td><td>-0.36</td><td>-1.41</td><td>0.043</td><td>0.897</td><td>1.000</td><td>2435</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>72</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>27</td><td>-0.40</td><td>-1.41</td><td>0.060</td><td>0.886</td><td>1.000</td><td>1937</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>73</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>58</td><td>-0.43</td><td>-1.41</td><td>0.022</td><td>0.886</td><td>1.000</td><td>3148</td><td>tags=64%, list=29%, signal=89%</td></tr><tr><td class='lessen'>74</td><td>EPPERT_PROGENITOR</td><td></td><td>74</td><td>-0.39</td><td>-1.41</td><td>0.120</td><td>0.881</td><td>1.000</td><td>2300</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>75</td><td>CROONQUIST_IL6_DEPRIVATION_DN</td><td></td><td>53</td><td>-0.57</td><td>-1.41</td><td>0.186</td><td>0.878</td><td>1.000</td><td>2289</td><td>tags=60%, list=21%, signal=76%</td></tr><tr><td class='lessen'>76</td><td>DANG_MYC_TARGETS_UP</td><td></td><td>69</td><td>-0.42</td><td>-1.41</td><td>0.120</td><td>0.867</td><td>1.000</td><td>1614</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>77</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>25</td><td>-0.44</td><td>-1.41</td><td>0.075</td><td>0.859</td><td>1.000</td><td>2082</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>78</td><td>RICKMAN_HEAD_AND_NECK_CANCER_B</td><td></td><td>21</td><td>-0.44</td><td>-1.41</td><td>0.115</td><td>0.856</td><td>1.000</td><td>3806</td><td>tags=57%, list=35%, signal=88%</td></tr><tr><td class='lessen'>79</td><td>WU_APOPTOSIS_BY_CDKN1A_VIA_TP53</td><td></td><td>28</td><td>-0.65</td><td>-1.40</td><td>0.205</td><td>0.850</td><td>1.000</td><td>2027</td><td>tags=68%, list=19%, signal=83%</td></tr><tr><td class='lessen'>80</td><td>NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON</td><td></td><td>37</td><td>-0.40</td><td>-1.40</td><td>0.091</td><td>0.839</td><td>1.000</td><td>1848</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>81</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>93</td><td>-0.43</td><td>-1.40</td><td>0.163</td><td>0.847</td><td>1.000</td><td>2271</td><td>tags=40%, list=21%, signal=50%</td></tr><tr><td class='lessen'>82</td><td>HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2</td><td></td><td>94</td><td>-0.34</td><td>-1.40</td><td>0.038</td><td>0.837</td><td>1.000</td><td>2194</td><td>tags=37%, list=20%, signal=46%</td></tr><tr><td class='lessen'>83</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>23</td><td>-0.51</td><td>-1.40</td><td>0.161</td><td>0.851</td><td>1.000</td><td>1461</td><td>tags=48%, list=13%, signal=55%</td></tr><tr><td class='lessen'>84</td><td>MASSARWEH_RESPONSE_TO_ESTRADIOL</td><td></td><td>28</td><td>-0.42</td><td>-1.40</td><td>0.074</td><td>0.845</td><td>1.000</td><td>1484</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>85</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>77</td><td>-0.41</td><td>-1.39</td><td>0.140</td><td>0.847</td><td>1.000</td><td>1489</td><td>tags=30%, list=14%, signal=34%</td></tr><tr><td class='lessen'>86</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_DN</td><td></td><td>104</td><td>-0.43</td><td>-1.39</td><td>0.073</td><td>0.847</td><td>1.000</td><td>2173</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>87</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>79</td><td>-0.33</td><td>-1.39</td><td>0.048</td><td>0.854</td><td>1.000</td><td>2261</td><td>tags=42%, list=21%, signal=52%</td></tr><tr><td class='lessen'>88</td><td>CHANG_CORE_SERUM_RESPONSE_UP</td><td></td><td>95</td><td>-0.37</td><td>-1.39</td><td>0.143</td><td>0.852</td><td>1.000</td><td>2966</td><td>tags=49%, list=27%, signal=67%</td></tr><tr><td class='lessen'>89</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>91</td><td>-0.52</td><td>-1.38</td><td>0.098</td><td>0.850</td><td>1.000</td><td>2280</td><td>tags=48%, list=21%, signal=61%</td></tr><tr><td class='lessen'>90</td><td>DELPUECH_FOXO3_TARGETS_DN</td><td></td><td>19</td><td>-0.60</td><td>-1.38</td><td>0.163</td><td>0.844</td><td>1.000</td><td>2048</td><td>tags=63%, list=19%, signal=78%</td></tr><tr><td class='lessen'>91</td><td>WANG_CLIM2_TARGETS_UP</td><td></td><td>138</td><td>-0.33</td><td>-1.38</td><td>0.085</td><td>0.835</td><td>1.000</td><td>2037</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>92</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</td><td></td><td>30</td><td>-0.47</td><td>-1.38</td><td>0.143</td><td>0.831</td><td>1.000</td><td>1253</td><td>tags=30%, list=12%, signal=34%</td></tr><tr><td class='lessen'>93</td><td>NADERI_BREAST_CANCER_PROGNOSIS_UP</td><td></td><td>23</td><td>-0.53</td><td>-1.38</td><td>0.196</td><td>0.831</td><td>1.000</td><td>2793</td><td>tags=61%, list=26%, signal=82%</td></tr><tr><td class='lessen'>94</td><td>GREENBAUM_E2A_TARGETS_UP</td><td></td><td>17</td><td>-0.67</td><td>-1.38</td><td>0.119</td><td>0.832</td><td>1.000</td><td>2965</td><td>tags=71%, list=27%, signal=97%</td></tr><tr><td class='lessen'>95</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>259</td><td>-0.32</td><td>-1.38</td><td>0.045</td><td>0.827</td><td>1.000</td><td>2479</td><td>tags=37%, list=23%, signal=47%</td></tr><tr><td class='lessen'>96</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN</td><td></td><td>38</td><td>-0.39</td><td>-1.38</td><td>0.070</td><td>0.824</td><td>1.000</td><td>1887</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>97</td><td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP</td><td></td><td>43</td><td>-0.40</td><td>-1.38</td><td>0.125</td><td>0.825</td><td>1.000</td><td>2490</td><td>tags=49%, list=23%, signal=63%</td></tr><tr><td class='lessen'>98</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>17</td><td>-0.54</td><td>-1.37</td><td>0.149</td><td>0.821</td><td>1.000</td><td>1815</td><td>tags=59%, list=17%, signal=70%</td></tr><tr><td class='lessen'>99</td><td>BENPORATH_OCT4_TARGETS</td><td></td><td>148</td><td>-0.33</td><td>-1.37</td><td>0.065</td><td>0.825</td><td>1.000</td><td>1842</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>100</td><td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</td><td></td><td>43</td><td>-0.35</td><td>-1.37</td><td>0.125</td><td>0.820</td><td>1.000</td><td>1912</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>101</td><td>WONG_EMBRYONIC_STEM_CELL_CORE</td><td></td><td>172</td><td>-0.44</td><td>-1.37</td><td>0.208</td><td>0.822</td><td>1.000</td><td>2194</td><td>tags=43%, list=20%, signal=53%</td></tr><tr><td class='lessen'>102</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</td><td></td><td>125</td><td>-0.34</td><td>-1.37</td><td>0.065</td><td>0.814</td><td>1.000</td><td>2083</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>103</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td><td></td><td>27</td><td>-0.41</td><td>-1.37</td><td>0.122</td><td>0.806</td><td>1.000</td><td>1424</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>104</td><td>PYEON_HPV_POSITIVE_TUMORS_UP</td><td></td><td>42</td><td>-0.53</td><td>-1.37</td><td>0.070</td><td>0.799</td><td>1.000</td><td>1829</td><td>tags=45%, list=17%, signal=54%</td></tr><tr><td class='lessen'>105</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP</td><td></td><td>56</td><td>-0.49</td><td>-1.37</td><td>0.205</td><td>0.793</td><td>1.000</td><td>2965</td><td>tags=57%, list=27%, signal=78%</td></tr><tr><td class='lessen'>106</td><td>KAUFFMANN_MELANOMA_RELAPSE_UP</td><td></td><td>32</td><td>-0.56</td><td>-1.36</td><td>0.140</td><td>0.801</td><td>1.000</td><td>2059</td><td>tags=56%, list=19%, signal=69%</td></tr><tr><td class='lessen'>107</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>284</td><td>-0.41</td><td>-1.36</td><td>0.093</td><td>0.796</td><td>1.000</td><td>2380</td><td>tags=42%, list=22%, signal=52%</td></tr><tr><td class='lessen'>108</td><td>OLSSON_E2F3_TARGETS_UP</td><td></td><td>17</td><td>-0.55</td><td>-1.36</td><td>0.176</td><td>0.794</td><td>1.000</td><td>1293</td><td>tags=41%, list=12%, signal=47%</td></tr><tr><td class='lessen'>109</td><td>WHITFIELD_CELL_CYCLE_G2_M</td><td></td><td>112</td><td>-0.39</td><td>-1.36</td><td>0.191</td><td>0.820</td><td>1.000</td><td>3111</td><td>tags=54%, list=29%, signal=75%</td></tr><tr><td class='lessen'>110</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</td><td></td><td>64</td><td>-0.36</td><td>-1.36</td><td>0.130</td><td>0.814</td><td>1.000</td><td>1904</td><td>tags=44%, list=17%, signal=53%</td></tr><tr><td class='lessen'>111</td><td>NAKAMURA_CANCER_MICROENVIRONMENT_DN</td><td></td><td>25</td><td>-0.50</td><td>-1.35</td><td>0.143</td><td>0.812</td><td>1.000</td><td>1253</td><td>tags=32%, list=12%, signal=36%</td></tr><tr><td class='lessen'>112</td><td>LU_TUMOR_VASCULATURE_UP</td><td></td><td>15</td><td>-0.59</td><td>-1.35</td><td>0.116</td><td>0.805</td><td>1.000</td><td>1266</td><td>tags=47%, list=12%, signal=53%</td></tr><tr><td class='lessen'>113</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>117</td><td>-0.32</td><td>-1.35</td><td>0.060</td><td>0.806</td><td>1.000</td><td>2651</td><td>tags=41%, list=24%, signal=54%</td></tr><tr><td class='lessen'>114</td><td>BROWNE_HCMV_INFECTION_1HR_DN</td><td></td><td>135</td><td>-0.32</td><td>-1.35</td><td>0.045</td><td>0.805</td><td>1.000</td><td>2359</td><td>tags=34%, list=22%, signal=43%</td></tr><tr><td class='lessen'>115</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP</td><td></td><td>24</td><td>-0.52</td><td>-1.35</td><td>0.159</td><td>0.804</td><td>1.000</td><td>2161</td><td>tags=50%, list=20%, signal=62%</td></tr><tr><td class='lessen'>116</td><td>PUJANA_CHEK2_PCC_NETWORK</td><td></td><td>390</td><td>-0.40</td><td>-1.35</td><td>0.116</td><td>0.797</td><td>1.000</td><td>2689</td><td>tags=43%, list=25%, signal=55%</td></tr><tr><td class='lessen'>117</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td><td></td><td>26</td><td>-0.47</td><td>-1.35</td><td>0.208</td><td>0.792</td><td>1.000</td><td>1127</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>118</td><td>CUI_GLUCOSE_DEPRIVATION</td><td></td><td>31</td><td>-0.42</td><td>-1.35</td><td>0.118</td><td>0.788</td><td>1.000</td><td>1960</td><td>tags=35%, list=18%, signal=43%</td></tr><tr><td class='lessen'>119</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>74</td><td>-0.39</td><td>-1.35</td><td>0.140</td><td>0.782</td><td>1.000</td><td>1867</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>120</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_UP</td><td></td><td>53</td><td>-0.35</td><td>-1.35</td><td>0.060</td><td>0.781</td><td>1.000</td><td>1646</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>121</td><td>VANHARANTA_UTERINE_FIBROID_UP</td><td></td><td>26</td><td>-0.42</td><td>-1.35</td><td>0.119</td><td>0.776</td><td>1.000</td><td>1796</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>122</td><td>MODY_HIPPOCAMPUS_NEONATAL</td><td></td><td>20</td><td>-0.48</td><td>-1.35</td><td>0.140</td><td>0.773</td><td>1.000</td><td>1357</td><td>tags=40%, list=12%, signal=46%</td></tr><tr><td class='lessen'>123</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>190</td><td>-0.45</td><td>-1.34</td><td>0.133</td><td>0.772</td><td>1.000</td><td>2637</td><td>tags=48%, list=24%, signal=63%</td></tr><tr><td class='lessen'>124</td><td>SMITH_TERT_TARGETS_UP</td><td></td><td>79</td><td>-0.30</td><td>-1.34</td><td>0.059</td><td>0.790</td><td>1.000</td><td>1937</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>125</td><td>WELCSH_BRCA1_TARGETS_DN</td><td></td><td>59</td><td>-0.40</td><td>-1.34</td><td>0.111</td><td>0.789</td><td>1.000</td><td>2434</td><td>tags=46%, list=22%, signal=59%</td></tr><tr><td class='lessen'>126</td><td>MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td><td></td><td>21</td><td>-0.41</td><td>-1.34</td><td>0.132</td><td>0.785</td><td>1.000</td><td>1980</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>127</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td><td></td><td>55</td><td>-0.38</td><td>-1.34</td><td>0.045</td><td>0.779</td><td>1.000</td><td>2780</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>128</td><td>RIZ_ERYTHROID_DIFFERENTIATION</td><td></td><td>42</td><td>-0.43</td><td>-1.34</td><td>0.178</td><td>0.776</td><td>1.000</td><td>1138</td><td>tags=31%, list=10%, signal=34%</td></tr><tr><td class='lessen'>129</td><td>PUJANA_BRCA2_PCC_NETWORK</td><td></td><td>225</td><td>-0.46</td><td>-1.33</td><td>0.128</td><td>0.773</td><td>1.000</td><td>2289</td><td>tags=44%, list=21%, signal=55%</td></tr><tr><td class='lessen'>130</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td><td></td><td>135</td><td>-0.35</td><td>-1.33</td><td>0.196</td><td>0.780</td><td>1.000</td><td>2309</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>131</td><td>BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2</td><td></td><td>35</td><td>-0.48</td><td>-1.33</td><td>0.140</td><td>0.786</td><td>1.000</td><td>1867</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>132</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN</td><td></td><td>45</td><td>-0.51</td><td>-1.33</td><td>0.240</td><td>0.790</td><td>1.000</td><td>2793</td><td>tags=64%, list=26%, signal=86%</td></tr><tr><td class='lessen'>133</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>159</td><td>-0.37</td><td>-1.33</td><td>0.163</td><td>0.785</td><td>1.000</td><td>1797</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>134</td><td>AMUNDSON_GAMMA_RADIATION_RESPONSE</td><td></td><td>18</td><td>-0.63</td><td>-1.32</td><td>0.214</td><td>0.784</td><td>1.000</td><td>2156</td><td>tags=56%, list=20%, signal=69%</td></tr><tr><td class='lessen'>135</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</td><td></td><td>26</td><td>-0.48</td><td>-1.32</td><td>0.136</td><td>0.787</td><td>1.000</td><td>1960</td><td>tags=46%, list=18%, signal=56%</td></tr><tr><td class='lessen'>136</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>132</td><td>-0.36</td><td>-1.32</td><td>0.180</td><td>0.782</td><td>1.000</td><td>1503</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>137</td><td>WHITFIELD_CELL_CYCLE_LITERATURE</td><td></td><td>28</td><td>-0.62</td><td>-1.32</td><td>0.220</td><td>0.783</td><td>1.000</td><td>2959</td><td>tags=75%, list=27%, signal=103%</td></tr><tr><td class='lessen'>138</td><td>SHEPARD_BMYB_TARGETS</td><td></td><td>39</td><td>-0.51</td><td>-1.32</td><td>0.244</td><td>0.778</td><td>1.000</td><td>2268</td><td>tags=54%, list=21%, signal=68%</td></tr><tr><td class='lessen'>139</td><td>PENG_GLUTAMINE_DEPRIVATION_DN</td><td></td><td>166</td><td>-0.39</td><td>-1.32</td><td>0.200</td><td>0.780</td><td>1.000</td><td>2802</td><td>tags=47%, list=26%, signal=62%</td></tr><tr><td class='lessen'>140</td><td>LEE_AGING_NEOCORTEX_DN</td><td></td><td>48</td><td>-0.33</td><td>-1.32</td><td>0.121</td><td>0.775</td><td>1.000</td><td>1428</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>141</td><td>MENSSEN_MYC_TARGETS</td><td></td><td>28</td><td>-0.47</td><td>-1.32</td><td>0.159</td><td>0.772</td><td>1.000</td><td>1525</td><td>tags=46%, list=14%, signal=54%</td></tr><tr><td class='lessen'>142</td><td>JOHNSTONE_PARVB_TARGETS_1_DN</td><td></td><td>31</td><td>-0.44</td><td>-1.32</td><td>0.149</td><td>0.770</td><td>1.000</td><td>1717</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>143</td><td>CHICAS_RB1_TARGETS_LOW_SERUM</td><td></td><td>48</td><td>-0.40</td><td>-1.31</td><td>0.208</td><td>0.773</td><td>1.000</td><td>2344</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>144</td><td>KAMMINGA_EZH2_TARGETS</td><td></td><td>22</td><td>-0.62</td><td>-1.31</td><td>0.178</td><td>0.783</td><td>1.000</td><td>1932</td><td>tags=59%, list=18%, signal=72%</td></tr><tr><td class='lessen'>145</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN</td><td></td><td>46</td><td>-0.35</td><td>-1.31</td><td>0.137</td><td>0.781</td><td>1.000</td><td>1933</td><td>tags=33%, list=18%, signal=39%</td></tr><tr><td class='lessen'>146</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>122</td><td>-0.33</td><td>-1.31</td><td>0.071</td><td>0.775</td><td>1.000</td><td>2117</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>147</td><td>DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY</td><td></td><td>21</td><td>-0.42</td><td>-1.31</td><td>0.111</td><td>0.782</td><td>1.000</td><td>2117</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>148</td><td>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN</td><td></td><td>27</td><td>-0.40</td><td>-1.31</td><td>0.085</td><td>0.779</td><td>1.000</td><td>1912</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>149</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>137</td><td>-0.34</td><td>-1.31</td><td>0.170</td><td>0.774</td><td>1.000</td><td>2282</td><td>tags=41%, list=21%, signal=51%</td></tr><tr><td class='lessen'>150</td><td>SESTO_RESPONSE_TO_UV_C2</td><td></td><td>35</td><td>-0.42</td><td>-1.31</td><td>0.160</td><td>0.771</td><td>1.000</td><td>1469</td><td>tags=37%, list=13%, signal=43%</td></tr><tr><td class='lessen'>151</td><td>ISHIDA_E2F_TARGETS</td><td></td><td>24</td><td>-0.70</td><td>-1.31</td><td>0.214</td><td>0.766</td><td>1.000</td><td>1960</td><td>tags=71%, list=18%, signal=86%</td></tr><tr><td class='lessen'>152</td><td>MORI_PRE_BI_LYMPHOCYTE_UP</td><td></td><td>36</td><td>-0.56</td><td>-1.30</td><td>0.234</td><td>0.768</td><td>1.000</td><td>2916</td><td>tags=67%, list=27%, signal=91%</td></tr><tr><td class='lessen'>153</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>89</td><td>-0.45</td><td>-1.30</td><td>0.222</td><td>0.767</td><td>1.000</td><td>2455</td><td>tags=44%, list=23%, signal=56%</td></tr><tr><td class='lessen'>154</td><td>LE_EGR2_TARGETS_UP</td><td></td><td>60</td><td>-0.48</td><td>-1.30</td><td>0.220</td><td>0.766</td><td>1.000</td><td>2570</td><td>tags=53%, list=24%, signal=69%</td></tr><tr><td class='lessen'>155</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>138</td><td>-0.38</td><td>-1.30</td><td>0.188</td><td>0.762</td><td>1.000</td><td>2728</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>156</td><td>LIAO_METASTASIS</td><td></td><td>289</td><td>-0.30</td><td>-1.30</td><td>0.132</td><td>0.768</td><td>1.000</td><td>2521</td><td>tags=35%, list=23%, signal=44%</td></tr><tr><td class='lessen'>157</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN</td><td></td><td>35</td><td>-0.44</td><td>-1.30</td><td>0.245</td><td>0.764</td><td>1.000</td><td>2455</td><td>tags=46%, list=23%, signal=59%</td></tr><tr><td class='lessen'>158</td><td>JAEGER_METASTASIS_UP</td><td></td><td>27</td><td>-0.39</td><td>-1.30</td><td>0.148</td><td>0.760</td><td>1.000</td><td>2748</td><td>tags=44%, list=25%, signal=59%</td></tr><tr><td class='lessen'>159</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td><td></td><td>23</td><td>-0.56</td><td>-1.30</td><td>0.239</td><td>0.757</td><td>1.000</td><td>2201</td><td>tags=52%, list=20%, signal=65%</td></tr><tr><td class='lessen'>160</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>175</td><td>-0.31</td><td>-1.30</td><td>0.196</td><td>0.754</td><td>1.000</td><td>1776</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>161</td><td>REICHERT_MITOSIS_LIN9_TARGETS</td><td></td><td>15</td><td>-0.70</td><td>-1.30</td><td>0.182</td><td>0.751</td><td>1.000</td><td>2156</td><td>tags=73%, list=20%, signal=91%</td></tr><tr><td class='lessen'>162</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP</td><td></td><td>24</td><td>-0.46</td><td>-1.30</td><td>0.244</td><td>0.747</td><td>1.000</td><td>1250</td><td>tags=33%, list=11%, signal=38%</td></tr><tr><td class='lessen'>163</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td><td></td><td>20</td><td>-0.44</td><td>-1.30</td><td>0.143</td><td>0.748</td><td>1.000</td><td>875</td><td>tags=30%, list=8%, signal=33%</td></tr><tr><td class='lessen'>164</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td><td></td><td>67</td><td>-0.32</td><td>-1.29</td><td>0.093</td><td>0.746</td><td>1.000</td><td>2584</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>165</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>78</td><td>-0.32</td><td>-1.29</td><td>0.160</td><td>0.755</td><td>1.000</td><td>2117</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>166</td><td>DAZARD_RESPONSE_TO_UV_SCC_DN</td><td></td><td>69</td><td>-0.37</td><td>-1.29</td><td>0.196</td><td>0.756</td><td>1.000</td><td>2805</td><td>tags=52%, list=26%, signal=70%</td></tr><tr><td class='lessen'>167</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>135</td><td>-0.39</td><td>-1.29</td><td>0.238</td><td>0.754</td><td>1.000</td><td>2918</td><td>tags=51%, list=27%, signal=69%</td></tr><tr><td class='lessen'>168</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>64</td><td>-0.37</td><td>-1.29</td><td>0.208</td><td>0.750</td><td>1.000</td><td>2309</td><td>tags=44%, list=21%, signal=55%</td></tr><tr><td class='lessen'>169</td><td>YEGNASUBRAMANIAN_PROSTATE_CANCER</td><td></td><td>65</td><td>-0.34</td><td>-1.29</td><td>0.137</td><td>0.747</td><td>1.000</td><td>2489</td><td>tags=37%, list=23%, signal=48%</td></tr><tr><td class='lessen'>170</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN</td><td></td><td>24</td><td>-0.43</td><td>-1.29</td><td>0.167</td><td>0.745</td><td>1.000</td><td>3065</td><td>tags=54%, list=28%, signal=75%</td></tr><tr><td class='lessen'>171</td><td>MANALO_HYPOXIA_DN</td><td></td><td>137</td><td>-0.41</td><td>-1.29</td><td>0.245</td><td>0.745</td><td>1.000</td><td>2342</td><td>tags=44%, list=22%, signal=55%</td></tr><tr><td class='lessen'>172</td><td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td><td></td><td>18</td><td>-0.51</td><td>-1.29</td><td>0.109</td><td>0.742</td><td>1.000</td><td>466</td><td>tags=33%, list=4%, signal=35%</td></tr><tr><td class='lessen'>173</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>84</td><td>-0.33</td><td>-1.29</td><td>0.113</td><td>0.738</td><td>1.000</td><td>2143</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>174</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>66</td><td>-0.50</td><td>-1.28</td><td>0.186</td><td>0.739</td><td>1.000</td><td>2280</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>175</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>74</td><td>-0.37</td><td>-1.28</td><td>0.136</td><td>0.743</td><td>1.000</td><td>2932</td><td>tags=50%, list=27%, signal=68%</td></tr><tr><td class='lessen'>176</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_UP</td><td></td><td>278</td><td>-0.42</td><td>-1.28</td><td>0.171</td><td>0.746</td><td>1.000</td><td>2225</td><td>tags=44%, list=20%, signal=53%</td></tr><tr><td class='lessen'>177</td><td>PENG_RAPAMYCIN_RESPONSE_DN</td><td></td><td>129</td><td>-0.33</td><td>-1.28</td><td>0.185</td><td>0.747</td><td>1.000</td><td>1986</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>178</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</td><td></td><td>65</td><td>-0.37</td><td>-1.28</td><td>0.158</td><td>0.752</td><td>1.000</td><td>2545</td><td>tags=43%, list=23%, signal=56%</td></tr><tr><td class='lessen'>179</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td><td></td><td>16</td><td>-0.39</td><td>-1.28</td><td>0.087</td><td>0.750</td><td>1.000</td><td>1139</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>180</td><td>GENTILE_UV_RESPONSE_CLUSTER_D4</td><td></td><td>32</td><td>-0.41</td><td>-1.27</td><td>0.239</td><td>0.751</td><td>1.000</td><td>1918</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>181</td><td>ROVERSI_GLIOMA_LOH_REGIONS</td><td></td><td>23</td><td>-0.39</td><td>-1.27</td><td>0.113</td><td>0.748</td><td>1.000</td><td>1348</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>182</td><td>BRUECKNER_TARGETS_OF_MIRLET7A3_DN</td><td></td><td>40</td><td>-0.36</td><td>-1.27</td><td>0.119</td><td>0.746</td><td>1.000</td><td>1393</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>183</td><td>IKEDA_MIR30_TARGETS_UP</td><td></td><td>65</td><td>-0.32</td><td>-1.27</td><td>0.114</td><td>0.744</td><td>1.000</td><td>1953</td><td>tags=37%, list=18%, signal=45%</td></tr><tr><td class='lessen'>184</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>244</td><td>-0.32</td><td>-1.27</td><td>0.128</td><td>0.740</td><td>1.000</td><td>2078</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>185</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_UP</td><td></td><td>54</td><td>-0.31</td><td>-1.27</td><td>0.082</td><td>0.737</td><td>1.000</td><td>1547</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>186</td><td>ZHANG_TLX_TARGETS_36HR_DN</td><td></td><td>89</td><td>-0.51</td><td>-1.27</td><td>0.190</td><td>0.733</td><td>1.000</td><td>2008</td><td>tags=48%, list=18%, signal=59%</td></tr><tr><td class='lessen'>187</td><td>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</td><td></td><td>74</td><td>-0.54</td><td>-1.27</td><td>0.390</td><td>0.731</td><td>1.000</td><td>2919</td><td>tags=65%, list=27%, signal=88%</td></tr><tr><td class='lessen'>188</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td><td></td><td>472</td><td>-0.32</td><td>-1.27</td><td>0.136</td><td>0.735</td><td>1.000</td><td>2283</td><td>tags=36%, list=21%, signal=43%</td></tr><tr><td class='lessen'>189</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>94</td><td>-0.45</td><td>-1.27</td><td>0.244</td><td>0.744</td><td>1.000</td><td>2316</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>190</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP</td><td></td><td>27</td><td>-0.37</td><td>-1.27</td><td>0.154</td><td>0.742</td><td>1.000</td><td>1177</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>191</td><td>CHIN_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>16</td><td>-0.47</td><td>-1.27</td><td>0.188</td><td>0.742</td><td>1.000</td><td>2977</td><td>tags=69%, list=27%, signal=94%</td></tr><tr><td class='lessen'>192</td><td>CERVERA_SDHB_TARGETS_1_DN</td><td></td><td>22</td><td>-0.38</td><td>-1.26</td><td>0.160</td><td>0.740</td><td>1.000</td><td>1657</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>193</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN</td><td></td><td>15</td><td>-0.42</td><td>-1.26</td><td>0.184</td><td>0.736</td><td>1.000</td><td>1858</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>194</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</td><td></td><td>52</td><td>-0.41</td><td>-1.26</td><td>0.286</td><td>0.737</td><td>1.000</td><td>2262</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>195</td><td>MCDOWELL_ACUTE_LUNG_INJURY_DN</td><td></td><td>37</td><td>-0.36</td><td>-1.26</td><td>0.145</td><td>0.735</td><td>1.000</td><td>1448</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>196</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP</td><td></td><td>18</td><td>-0.44</td><td>-1.26</td><td>0.184</td><td>0.732</td><td>1.000</td><td>1940</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>197</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>408</td><td>-0.34</td><td>-1.26</td><td>0.184</td><td>0.730</td><td>1.000</td><td>2824</td><td>tags=42%, list=26%, signal=55%</td></tr><tr><td class='lessen'>198</td><td>SHEPARD_BMYB_MORPHOLINO_DN</td><td></td><td>110</td><td>-0.30</td><td>-1.26</td><td>0.220</td><td>0.731</td><td>1.000</td><td>1777</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>199</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td><td></td><td>151</td><td>-0.30</td><td>-1.26</td><td>0.189</td><td>0.740</td><td>1.000</td><td>1718</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>200</td><td>MORI_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>50</td><td>-0.52</td><td>-1.26</td><td>0.295</td><td>0.738</td><td>1.000</td><td>2200</td><td>tags=52%, list=20%, signal=65%</td></tr><tr><td class='lessen'>201</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP</td><td></td><td>28</td><td>-0.41</td><td>-1.26</td><td>0.250</td><td>0.736</td><td>1.000</td><td>2536</td><td>tags=46%, list=23%, signal=60%</td></tr><tr><td class='lessen'>202</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>210</td><td>-0.30</td><td>-1.26</td><td>0.146</td><td>0.732</td><td>1.000</td><td>2252</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>203</td><td>SESTO_RESPONSE_TO_UV_C6</td><td></td><td>15</td><td>-0.48</td><td>-1.26</td><td>0.292</td><td>0.730</td><td>1.000</td><td>2177</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>204</td><td>HOELZEL_NF1_TARGETS_DN</td><td></td><td>56</td><td>-0.35</td><td>-1.25</td><td>0.182</td><td>0.730</td><td>1.000</td><td>1839</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>205</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</td><td></td><td>42</td><td>-0.36</td><td>-1.25</td><td>0.146</td><td>0.728</td><td>1.000</td><td>1477</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>206</td><td>APRELIKOVA_BRCA1_TARGETS</td><td></td><td>28</td><td>-0.40</td><td>-1.25</td><td>0.213</td><td>0.726</td><td>1.000</td><td>2007</td><td>tags=46%, list=18%, signal=57%</td></tr><tr><td class='lessen'>207</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td><td></td><td>33</td><td>-0.39</td><td>-1.25</td><td>0.120</td><td>0.723</td><td>1.000</td><td>1960</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>208</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP</td><td></td><td>51</td><td>-0.34</td><td>-1.25</td><td>0.151</td><td>0.725</td><td>1.000</td><td>2263</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>209</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP</td><td></td><td>16</td><td>-0.43</td><td>-1.25</td><td>0.234</td><td>0.723</td><td>1.000</td><td>2397</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>210</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP</td><td></td><td>83</td><td>-0.28</td><td>-1.25</td><td>0.102</td><td>0.721</td><td>1.000</td><td>1640</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>211</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_DN</td><td></td><td>43</td><td>-0.40</td><td>-1.25</td><td>0.229</td><td>0.719</td><td>1.000</td><td>3444</td><td>tags=51%, list=32%, signal=75%</td></tr><tr><td class='lessen'>212</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td><td></td><td>103</td><td>-0.27</td><td>-1.25</td><td>0.023</td><td>0.717</td><td>1.000</td><td>1433</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>213</td><td>MARKEY_RB1_ACUTE_LOF_UP</td><td></td><td>121</td><td>-0.44</td><td>-1.25</td><td>0.209</td><td>0.717</td><td>1.000</td><td>2562</td><td>tags=47%, list=24%, signal=61%</td></tr><tr><td class='lessen'>214</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>290</td><td>-0.27</td><td>-1.25</td><td>0.173</td><td>0.717</td><td>1.000</td><td>2379</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>215</td><td>FARMER_BREAST_CANCER_CLUSTER_2</td><td></td><td>15</td><td>-0.65</td><td>-1.25</td><td>0.302</td><td>0.714</td><td>1.000</td><td>2932</td><td>tags=80%, list=27%, signal=109%</td></tr><tr><td class='lessen'>216</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>82</td><td>-0.33</td><td>-1.25</td><td>0.184</td><td>0.711</td><td>1.000</td><td>1960</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>217</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</td><td></td><td>108</td><td>-0.38</td><td>-1.25</td><td>0.294</td><td>0.708</td><td>1.000</td><td>3021</td><td>tags=53%, list=28%, signal=72%</td></tr><tr><td class='lessen'>218</td><td>BONCI_TARGETS_OF_MIR15A_AND_MIR16_1</td><td></td><td>51</td><td>-0.32</td><td>-1.25</td><td>0.167</td><td>0.708</td><td>1.000</td><td>1912</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>219</td><td>KONG_E2F3_TARGETS</td><td></td><td>45</td><td>-0.54</td><td>-1.25</td><td>0.357</td><td>0.705</td><td>1.000</td><td>2156</td><td>tags=51%, list=20%, signal=63%</td></tr><tr><td class='lessen'>220</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>276</td><td>-0.26</td><td>-1.25</td><td>0.130</td><td>0.703</td><td>1.000</td><td>1953</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>221</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</td><td></td><td>62</td><td>-0.58</td><td>-1.25</td><td>0.244</td><td>0.703</td><td>1.000</td><td>2176</td><td>tags=63%, list=20%, signal=78%</td></tr><tr><td class='lessen'>222</td><td>WHITEFORD_PEDIATRIC_CANCER_MARKERS</td><td></td><td>57</td><td>-0.56</td><td>-1.25</td><td>0.300</td><td>0.702</td><td>1.000</td><td>2176</td><td>tags=58%, list=20%, signal=72%</td></tr><tr><td class='lessen'>223</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td><td></td><td>32</td><td>-0.42</td><td>-1.24</td><td>0.205</td><td>0.703</td><td>1.000</td><td>3621</td><td>tags=66%, list=33%, signal=98%</td></tr><tr><td class='lessen'>224</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td><td></td><td>72</td><td>-0.32</td><td>-1.24</td><td>0.196</td><td>0.700</td><td>1.000</td><td>2337</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>225</td><td>WONG_PROTEASOME_GENE_MODULE</td><td></td><td>28</td><td>-0.39</td><td>-1.24</td><td>0.250</td><td>0.698</td><td>1.000</td><td>1786</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>226</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>266</td><td>-0.32</td><td>-1.24</td><td>0.182</td><td>0.699</td><td>1.000</td><td>1821</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>227</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>15</td><td>-0.51</td><td>-1.24</td><td>0.250</td><td>0.696</td><td>1.000</td><td>2148</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>228</td><td>POOLA_INVASIVE_BREAST_CANCER_DN</td><td></td><td>78</td><td>-0.30</td><td>-1.24</td><td>0.183</td><td>0.694</td><td>1.000</td><td>2248</td><td>tags=35%, list=21%, signal=43%</td></tr><tr><td class='lessen'>229</td><td>ZHANG_TLX_TARGETS_DN</td><td></td><td>41</td><td>-0.57</td><td>-1.24</td><td>0.238</td><td>0.696</td><td>1.000</td><td>2793</td><td>tags=61%, list=26%, signal=82%</td></tr><tr><td class='lessen'>230</td><td>GABRIELY_MIR21_TARGETS</td><td></td><td>155</td><td>-0.36</td><td>-1.24</td><td>0.283</td><td>0.696</td><td>1.000</td><td>3292</td><td>tags=55%, list=30%, signal=78%</td></tr><tr><td class='lessen'>231</td><td>BENPORATH_NOS_TARGETS</td><td></td><td>91</td><td>-0.31</td><td>-1.24</td><td>0.250</td><td>0.703</td><td>1.000</td><td>1749</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>232</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_DN</td><td></td><td>119</td><td>-0.50</td><td>-1.24</td><td>0.275</td><td>0.703</td><td>1.000</td><td>2176</td><td>tags=52%, list=20%, signal=64%</td></tr><tr><td class='lessen'>233</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</td><td></td><td>80</td><td>-0.43</td><td>-1.23</td><td>0.270</td><td>0.705</td><td>1.000</td><td>2464</td><td>tags=54%, list=23%, signal=69%</td></tr><tr><td class='lessen'>234</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP</td><td></td><td>70</td><td>-0.32</td><td>-1.23</td><td>0.200</td><td>0.703</td><td>1.000</td><td>1796</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>235</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>31</td><td>-0.36</td><td>-1.23</td><td>0.212</td><td>0.703</td><td>1.000</td><td>2795</td><td>tags=55%, list=26%, signal=74%</td></tr><tr><td class='lessen'>236</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>83</td><td>-0.49</td><td>-1.23</td><td>0.282</td><td>0.701</td><td>1.000</td><td>1960</td><td>tags=47%, list=18%, signal=57%</td></tr><tr><td class='lessen'>237</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN</td><td></td><td>46</td><td>-0.32</td><td>-1.23</td><td>0.093</td><td>0.698</td><td>1.000</td><td>1586</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>238</td><td>KASLER_HDAC7_TARGETS_2_DN</td><td></td><td>18</td><td>-0.46</td><td>-1.23</td><td>0.245</td><td>0.695</td><td>1.000</td><td>2181</td><td>tags=50%, list=20%, signal=62%</td></tr><tr><td class='lessen'>239</td><td>FURUKAWA_DUSP6_TARGETS_PCI35_DN</td><td></td><td>33</td><td>-0.45</td><td>-1.23</td><td>0.375</td><td>0.698</td><td>1.000</td><td>2846</td><td>tags=58%, list=26%, signal=78%</td></tr><tr><td class='lessen'>240</td><td>VANTVEER_BREAST_CANCER_METASTASIS_UP</td><td></td><td>29</td><td>-0.38</td><td>-1.23</td><td>0.213</td><td>0.705</td><td>1.000</td><td>2130</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>241</td><td>GUO_TARGETS_OF_IRS1_AND_IRS2</td><td></td><td>60</td><td>-0.32</td><td>-1.23</td><td>0.154</td><td>0.705</td><td>1.000</td><td>1337</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>242</td><td>PATIL_LIVER_CANCER</td><td></td><td>367</td><td>-0.27</td><td>-1.23</td><td>0.212</td><td>0.703</td><td>1.000</td><td>2305</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>243</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>212</td><td>-0.26</td><td>-1.23</td><td>0.159</td><td>0.700</td><td>1.000</td><td>2337</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>244</td><td>PECE_MAMMARY_STEM_CELL_DN</td><td></td><td>77</td><td>-0.33</td><td>-1.23</td><td>0.200</td><td>0.698</td><td>1.000</td><td>2742</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>245</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>210</td><td>-0.34</td><td>-1.22</td><td>0.233</td><td>0.708</td><td>1.000</td><td>2289</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>246</td><td>BECKER_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>30</td><td>-0.36</td><td>-1.22</td><td>0.180</td><td>0.706</td><td>1.000</td><td>1912</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>247</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>257</td><td>-0.30</td><td>-1.22</td><td>0.213</td><td>0.703</td><td>1.000</td><td>2340</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>248</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td><td></td><td>115</td><td>-0.28</td><td>-1.22</td><td>0.137</td><td>0.701</td><td>1.000</td><td>1349</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>249</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>27</td><td>-0.40</td><td>-1.22</td><td>0.218</td><td>0.698</td><td>1.000</td><td>1439</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>250</td><td>VANTVEER_BREAST_CANCER_POOR_PROGNOSIS</td><td></td><td>24</td><td>-0.38</td><td>-1.22</td><td>0.208</td><td>0.697</td><td>1.000</td><td>2728</td><td>tags=42%, list=25%, signal=55%</td></tr><tr><td class='lessen'>251</td><td>BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE</td><td></td><td>35</td><td>-0.41</td><td>-1.22</td><td>0.311</td><td>0.697</td><td>1.000</td><td>3397</td><td>tags=49%, list=31%, signal=70%</td></tr><tr><td class='lessen'>252</td><td>BIDUS_METASTASIS_UP</td><td></td><td>105</td><td>-0.44</td><td>-1.22</td><td>0.214</td><td>0.694</td><td>1.000</td><td>2620</td><td>tags=56%, list=24%, signal=73%</td></tr><tr><td class='lessen'>253</td><td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN</td><td></td><td>15</td><td>-0.41</td><td>-1.22</td><td>0.157</td><td>0.699</td><td>1.000</td><td>1397</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>254</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>54</td><td>-0.37</td><td>-1.22</td><td>0.222</td><td>0.701</td><td>1.000</td><td>2743</td><td>tags=43%, list=25%, signal=57%</td></tr><tr><td class='lessen'>255</td><td>ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE</td><td></td><td>31</td><td>-0.35</td><td>-1.21</td><td>0.240</td><td>0.707</td><td>1.000</td><td>2180</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>256</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>108</td><td>-0.27</td><td>-1.21</td><td>0.143</td><td>0.708</td><td>1.000</td><td>2412</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>257</td><td>QI_PLASMACYTOMA_DN</td><td></td><td>56</td><td>-0.32</td><td>-1.21</td><td>0.226</td><td>0.708</td><td>1.000</td><td>2450</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>258</td><td>RIZ_ERYTHROID_DIFFERENTIATION_12HR</td><td></td><td>31</td><td>-0.44</td><td>-1.21</td><td>0.280</td><td>0.712</td><td>1.000</td><td>2167</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>259</td><td>RODRIGUES_NTN1_TARGETS_DN</td><td></td><td>88</td><td>-0.31</td><td>-1.21</td><td>0.133</td><td>0.711</td><td>1.000</td><td>2222</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>260</td><td>ZHANG_TLX_TARGETS_60HR_DN</td><td></td><td>128</td><td>-0.46</td><td>-1.21</td><td>0.195</td><td>0.710</td><td>1.000</td><td>2918</td><td>tags=55%, list=27%, signal=75%</td></tr><tr><td class='lessen'>261</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_UP</td><td></td><td>55</td><td>-0.32</td><td>-1.21</td><td>0.236</td><td>0.716</td><td>1.000</td><td>1829</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>262</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</td><td></td><td>88</td><td>-0.39</td><td>-1.21</td><td>0.366</td><td>0.714</td><td>1.000</td><td>3040</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>263</td><td>KAUFFMANN_DNA_REPLICATION_GENES</td><td></td><td>78</td><td>-0.32</td><td>-1.21</td><td>0.250</td><td>0.713</td><td>1.000</td><td>2059</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>264</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN</td><td></td><td>47</td><td>-0.38</td><td>-1.20</td><td>0.283</td><td>0.713</td><td>1.000</td><td>2603</td><td>tags=49%, list=24%, signal=64%</td></tr><tr><td class='lessen'>265</td><td>SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER</td><td></td><td>58</td><td>-0.34</td><td>-1.20</td><td>0.208</td><td>0.711</td><td>1.000</td><td>2117</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>266</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN</td><td></td><td>35</td><td>-0.36</td><td>-1.20</td><td>0.234</td><td>0.712</td><td>1.000</td><td>1744</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>267</td><td>LIU_COMMON_CANCER_GENES</td><td></td><td>40</td><td>-0.39</td><td>-1.20</td><td>0.311</td><td>0.711</td><td>1.000</td><td>2024</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>268</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td><td></td><td>83</td><td>-0.41</td><td>-1.20</td><td>0.364</td><td>0.712</td><td>1.000</td><td>2271</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>269</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>317</td><td>-0.33</td><td>-1.20</td><td>0.256</td><td>0.711</td><td>1.000</td><td>2289</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>270</td><td>GRADE_METASTASIS_DN</td><td></td><td>21</td><td>-0.46</td><td>-1.20</td><td>0.245</td><td>0.709</td><td>1.000</td><td>1547</td><td>tags=38%, list=14%, signal=44%</td></tr><tr><td class='lessen'>271</td><td>CHICAS_RB1_TARGETS_GROWING</td><td></td><td>139</td><td>-0.37</td><td>-1.20</td><td>0.262</td><td>0.709</td><td>1.000</td><td>2595</td><td>tags=46%, list=24%, signal=60%</td></tr><tr><td class='lessen'>272</td><td>GUILLAUMOND_KLF10_TARGETS_UP</td><td></td><td>18</td><td>-0.42</td><td>-1.20</td><td>0.292</td><td>0.708</td><td>1.000</td><td>2052</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>273</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_UP</td><td></td><td>57</td><td>-0.32</td><td>-1.20</td><td>0.186</td><td>0.707</td><td>1.000</td><td>1646</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>274</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>218</td><td>-0.37</td><td>-1.20</td><td>0.238</td><td>0.705</td><td>1.000</td><td>3309</td><td>tags=51%, list=30%, signal=72%</td></tr><tr><td class='lessen'>275</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>183</td><td>-0.28</td><td>-1.19</td><td>0.260</td><td>0.714</td><td>1.000</td><td>1904</td><td>tags=30%, list=17%, signal=35%</td></tr><tr><td class='lessen'>276</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>38</td><td>-0.45</td><td>-1.19</td><td>0.314</td><td>0.713</td><td>1.000</td><td>896</td><td>tags=29%, list=8%, signal=31%</td></tr><tr><td class='lessen'>277</td><td>WEI_MIR34A_TARGETS</td><td></td><td>80</td><td>-0.31</td><td>-1.19</td><td>0.232</td><td>0.712</td><td>1.000</td><td>2700</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>278</td><td>WANG_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>20</td><td>-0.38</td><td>-1.19</td><td>0.145</td><td>0.709</td><td>1.000</td><td>3113</td><td>tags=50%, list=29%, signal=70%</td></tr><tr><td class='lessen'>279</td><td>HOOI_ST7_TARGETS_DN</td><td></td><td>60</td><td>-0.29</td><td>-1.19</td><td>0.150</td><td>0.711</td><td>1.000</td><td>1641</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>280</td><td>MOHANKUMAR_TLX1_TARGETS_UP</td><td></td><td>214</td><td>-0.28</td><td>-1.19</td><td>0.196</td><td>0.710</td><td>1.000</td><td>2603</td><td>tags=40%, list=24%, signal=51%</td></tr><tr><td class='lessen'>281</td><td>WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT</td><td></td><td>38</td><td>-0.34</td><td>-1.19</td><td>0.149</td><td>0.711</td><td>1.000</td><td>2267</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>282</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>165</td><td>-0.36</td><td>-1.19</td><td>0.298</td><td>0.711</td><td>1.000</td><td>2043</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>283</td><td>KYNG_NORMAL_AGING_DN</td><td></td><td>16</td><td>-0.41</td><td>-1.19</td><td>0.143</td><td>0.710</td><td>1.000</td><td>2206</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>284</td><td>OXFORD_RALA_OR_RALB_TARGETS_UP</td><td></td><td>24</td><td>-0.54</td><td>-1.19</td><td>0.317</td><td>0.711</td><td>1.000</td><td>3792</td><td>tags=88%, list=35%, signal=134%</td></tr><tr><td class='lessen'>285</td><td>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP</td><td></td><td>15</td><td>-0.44</td><td>-1.19</td><td>0.261</td><td>0.710</td><td>1.000</td><td>1689</td><td>tags=40%, list=16%, signal=47%</td></tr><tr><td class='lessen'>286</td><td>MATTIOLI_MGUS_VS_PCL</td><td></td><td>62</td><td>-0.38</td><td>-1.19</td><td>0.271</td><td>0.707</td><td>1.000</td><td>3260</td><td>tags=53%, list=30%, signal=76%</td></tr><tr><td class='lessen'>287</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</td><td></td><td>72</td><td>-0.51</td><td>-1.19</td><td>0.275</td><td>0.710</td><td>1.000</td><td>2793</td><td>tags=61%, list=26%, signal=82%</td></tr><tr><td class='lessen'>288</td><td>PENG_LEUCINE_DEPRIVATION_DN</td><td></td><td>97</td><td>-0.37</td><td>-1.19</td><td>0.271</td><td>0.707</td><td>1.000</td><td>2621</td><td>tags=43%, list=24%, signal=57%</td></tr><tr><td class='lessen'>289</td><td>HELLER_SILENCED_BY_METHYLATION_DN</td><td></td><td>60</td><td>-0.29</td><td>-1.19</td><td>0.127</td><td>0.706</td><td>1.000</td><td>1343</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>290</td><td>BILANGES_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>15</td><td>-0.39</td><td>-1.19</td><td>0.250</td><td>0.704</td><td>1.000</td><td>1194</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>291</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN</td><td></td><td>33</td><td>-0.38</td><td>-1.18</td><td>0.220</td><td>0.704</td><td>1.000</td><td>2416</td><td>tags=48%, list=22%, signal=62%</td></tr><tr><td class='lessen'>292</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>133</td><td>-0.30</td><td>-1.18</td><td>0.179</td><td>0.702</td><td>1.000</td><td>2133</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>293</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP</td><td></td><td>78</td><td>-0.27</td><td>-1.18</td><td>0.180</td><td>0.702</td><td>1.000</td><td>1281</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>294</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td><td></td><td>59</td><td>-0.51</td><td>-1.18</td><td>0.262</td><td>0.704</td><td>1.000</td><td>2201</td><td>tags=51%, list=20%, signal=63%</td></tr><tr><td class='lessen'>295</td><td>ROVERSI_GLIOMA_COPY_NUMBER_DN</td><td></td><td>36</td><td>-0.30</td><td>-1.18</td><td>0.159</td><td>0.702</td><td>1.000</td><td>2126</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>296</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_UP</td><td></td><td>63</td><td>-0.31</td><td>-1.18</td><td>0.236</td><td>0.702</td><td>1.000</td><td>1150</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>297</td><td>SESTO_RESPONSE_TO_UV_C5</td><td></td><td>29</td><td>-0.33</td><td>-1.18</td><td>0.188</td><td>0.703</td><td>1.000</td><td>1249</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>298</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>137</td><td>-0.29</td><td>-1.18</td><td>0.255</td><td>0.701</td><td>1.000</td><td>2380</td><td>tags=35%, list=22%, signal=44%</td></tr><tr><td class='lessen'>299</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>48</td><td>-0.30</td><td>-1.18</td><td>0.191</td><td>0.704</td><td>1.000</td><td>1886</td><td>tags=35%, list=17%, signal=43%</td></tr><tr><td class='lessen'>300</td><td>LINSLEY_MIR16_TARGETS</td><td></td><td>103</td><td>-0.28</td><td>-1.18</td><td>0.228</td><td>0.704</td><td>1.000</td><td>1793</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>301</td><td>KANG_DOXORUBICIN_RESISTANCE_UP</td><td></td><td>31</td><td>-0.62</td><td>-1.18</td><td>0.341</td><td>0.706</td><td>1.000</td><td>2048</td><td>tags=58%, list=19%, signal=71%</td></tr><tr><td class='lessen'>302</td><td>REN_BOUND_BY_E2F</td><td></td><td>27</td><td>-0.47</td><td>-1.18</td><td>0.365</td><td>0.705</td><td>1.000</td><td>2200</td><td>tags=41%, list=20%, signal=51%</td></tr><tr><td class='lessen'>303</td><td>FUJII_YBX1_TARGETS_DN</td><td></td><td>113</td><td>-0.41</td><td>-1.17</td><td>0.286</td><td>0.707</td><td>1.000</td><td>2176</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>304</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_UP</td><td></td><td>42</td><td>-0.31</td><td>-1.17</td><td>0.234</td><td>0.705</td><td>1.000</td><td>1796</td><td>tags=36%, list=17%, signal=43%</td></tr><tr><td class='lessen'>305</td><td>UEDA_PERIFERAL_CLOCK</td><td></td><td>80</td><td>-0.31</td><td>-1.17</td><td>0.196</td><td>0.704</td><td>1.000</td><td>2022</td><td>tags=34%, list=19%, signal=41%</td></tr><tr><td class='lessen'>306</td><td>GRADE_COLON_CANCER_UP</td><td></td><td>414</td><td>-0.27</td><td>-1.17</td><td>0.191</td><td>0.705</td><td>1.000</td><td>2680</td><td>tags=36%, list=25%, signal=46%</td></tr><tr><td class='lessen'>307</td><td>MAHAJAN_RESPONSE_TO_IL1A_DN</td><td></td><td>45</td><td>-0.36</td><td>-1.17</td><td>0.255</td><td>0.708</td><td>1.000</td><td>1699</td><td>tags=27%, list=16%, signal=31%</td></tr><tr><td class='lessen'>308</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>161</td><td>-0.34</td><td>-1.17</td><td>0.271</td><td>0.706</td><td>1.000</td><td>2181</td><td>tags=37%, list=20%, signal=45%</td></tr><tr><td class='lessen'>309</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>215</td><td>-0.33</td><td>-1.17</td><td>0.264</td><td>0.706</td><td>1.000</td><td>2398</td><td>tags=39%, list=22%, signal=49%</td></tr><tr><td class='lessen'>310</td><td>MANTOVANI_VIRAL_GPCR_SIGNALING_DN</td><td></td><td>24</td><td>-0.37</td><td>-1.17</td><td>0.340</td><td>0.705</td><td>1.000</td><td>1362</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>311</td><td>BENPORATH_SOX2_TARGETS</td><td></td><td>368</td><td>-0.28</td><td>-1.17</td><td>0.208</td><td>0.705</td><td>1.000</td><td>2188</td><td>tags=32%, list=20%, signal=38%</td></tr><tr><td class='lessen'>312</td><td>HADDAD_B_LYMPHOCYTE_PROGENITOR</td><td></td><td>173</td><td>-0.27</td><td>-1.17</td><td>0.167</td><td>0.703</td><td>1.000</td><td>1759</td><td>tags=27%, list=16%, signal=31%</td></tr><tr><td class='lessen'>313</td><td>YU_MYC_TARGETS_UP</td><td></td><td>25</td><td>-0.53</td><td>-1.17</td><td>0.367</td><td>0.702</td><td>1.000</td><td>2959</td><td>tags=68%, list=27%, signal=93%</td></tr><tr><td class='lessen'>314</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>448</td><td>-0.32</td><td>-1.17</td><td>0.319</td><td>0.707</td><td>1.000</td><td>2176</td><td>tags=34%, list=20%, signal=40%</td></tr><tr><td class='lessen'>315</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN</td><td></td><td>22</td><td>-0.36</td><td>-1.16</td><td>0.255</td><td>0.707</td><td>1.000</td><td>2097</td><td>tags=41%, list=19%, signal=51%</td></tr><tr><td class='lessen'>316</td><td>SANSOM_APC_TARGETS</td><td></td><td>99</td><td>-0.27</td><td>-1.16</td><td>0.178</td><td>0.707</td><td>1.000</td><td>1411</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>317</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td><td></td><td>33</td><td>-0.34</td><td>-1.16</td><td>0.269</td><td>0.705</td><td>1.000</td><td>2597</td><td>tags=39%, list=24%, signal=52%</td></tr><tr><td class='lessen'>318</td><td>CADWELL_ATG16L1_TARGETS_DN</td><td></td><td>33</td><td>-0.33</td><td>-1.16</td><td>0.217</td><td>0.706</td><td>1.000</td><td>1352</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>319</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td><td></td><td>176</td><td>-0.28</td><td>-1.16</td><td>0.178</td><td>0.712</td><td>1.000</td><td>2012</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>320</td><td>LOPEZ_TRANSLATION_VIA_FN1_SIGNALING</td><td></td><td>19</td><td>-0.42</td><td>-1.16</td><td>0.250</td><td>0.713</td><td>1.000</td><td>2161</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>321</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>154</td><td>-0.27</td><td>-1.16</td><td>0.250</td><td>0.713</td><td>1.000</td><td>2159</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>322</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>49</td><td>-0.30</td><td>-1.16</td><td>0.240</td><td>0.715</td><td>1.000</td><td>2199</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>323</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td><td></td><td>185</td><td>-0.36</td><td>-1.16</td><td>0.319</td><td>0.715</td><td>1.000</td><td>2194</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>324</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</td><td></td><td>40</td><td>-0.52</td><td>-1.16</td><td>0.300</td><td>0.715</td><td>1.000</td><td>3298</td><td>tags=65%, list=30%, signal=93%</td></tr><tr><td class='lessen'>325</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td><td></td><td>123</td><td>-0.27</td><td>-1.15</td><td>0.167</td><td>0.717</td><td>1.000</td><td>2528</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>326</td><td>CHANGOLKAR_H2AFY_TARGETS_UP</td><td></td><td>29</td><td>-0.33</td><td>-1.15</td><td>0.184</td><td>0.717</td><td>1.000</td><td>2004</td><td>tags=41%, list=18%, signal=51%</td></tr><tr><td class='lessen'>327</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>133</td><td>-0.31</td><td>-1.15</td><td>0.341</td><td>0.716</td><td>1.000</td><td>2253</td><td>tags=35%, list=21%, signal=43%</td></tr><tr><td class='lessen'>328</td><td>SWEET_KRAS_TARGETS_DN</td><td></td><td>35</td><td>-0.33</td><td>-1.15</td><td>0.302</td><td>0.716</td><td>1.000</td><td>2380</td><td>tags=43%, list=22%, signal=55%</td></tr><tr><td class='lessen'>329</td><td>ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP</td><td></td><td>44</td><td>-0.32</td><td>-1.15</td><td>0.255</td><td>0.720</td><td>1.000</td><td>2091</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>330</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</td><td></td><td>91</td><td>-0.34</td><td>-1.15</td><td>0.311</td><td>0.722</td><td>1.000</td><td>1925</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>331</td><td>WHITFIELD_CELL_CYCLE_G2</td><td></td><td>83</td><td>-0.31</td><td>-1.15</td><td>0.222</td><td>0.721</td><td>1.000</td><td>3014</td><td>tags=45%, list=28%, signal=61%</td></tr><tr><td class='lessen'>332</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>355</td><td>-0.25</td><td>-1.15</td><td>0.273</td><td>0.719</td><td>1.000</td><td>1823</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>333</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td><td></td><td>397</td><td>-0.28</td><td>-1.15</td><td>0.292</td><td>0.717</td><td>1.000</td><td>2283</td><td>tags=31%, list=21%, signal=38%</td></tr><tr><td class='lessen'>334</td><td>MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER</td><td></td><td>22</td><td>-0.36</td><td>-1.15</td><td>0.259</td><td>0.717</td><td>1.000</td><td>433</td><td>tags=18%, list=4%, signal=19%</td></tr><tr><td class='lessen'>335</td><td>CAIRO_HEPATOBLASTOMA_UP</td><td></td><td>106</td><td>-0.29</td><td>-1.15</td><td>0.326</td><td>0.715</td><td>1.000</td><td>1743</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>336</td><td>RUIZ_TNC_TARGETS_DN</td><td></td><td>83</td><td>-0.35</td><td>-1.15</td><td>0.317</td><td>0.715</td><td>1.000</td><td>2380</td><td>tags=45%, list=22%, signal=57%</td></tr><tr><td class='lessen'>337</td><td>HEDENFALK_BREAST_CANCER_BRACX_DN</td><td></td><td>16</td><td>-0.35</td><td>-1.15</td><td>0.304</td><td>0.713</td><td>1.000</td><td>2002</td><td>tags=44%, list=18%, signal=54%</td></tr><tr><td class='lessen'>338</td><td>DOANE_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>135</td><td>-0.26</td><td>-1.14</td><td>0.244</td><td>0.714</td><td>1.000</td><td>2565</td><td>tags=36%, list=24%, signal=46%</td></tr><tr><td class='lessen'>339</td><td>ZAMORA_NOS2_TARGETS_UP</td><td></td><td>35</td><td>-0.35</td><td>-1.14</td><td>0.265</td><td>0.712</td><td>1.000</td><td>2239</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>340</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>159</td><td>-0.31</td><td>-1.14</td><td>0.289</td><td>0.710</td><td>1.000</td><td>1758</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>341</td><td>KAMMINGA_SENESCENCE</td><td></td><td>19</td><td>-0.41</td><td>-1.14</td><td>0.354</td><td>0.709</td><td>1.000</td><td>2999</td><td>tags=58%, list=28%, signal=80%</td></tr><tr><td class='lessen'>342</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP</td><td></td><td>171</td><td>-0.40</td><td>-1.14</td><td>0.395</td><td>0.709</td><td>1.000</td><td>2965</td><td>tags=50%, list=27%, signal=67%</td></tr><tr><td class='lessen'>343</td><td>GENTILE_UV_RESPONSE_CLUSTER_D8</td><td></td><td>22</td><td>-0.36</td><td>-1.14</td><td>0.288</td><td>0.707</td><td>1.000</td><td>3398</td><td>tags=55%, list=31%, signal=79%</td></tr><tr><td class='lessen'>344</td><td>BENPORATH_PROLIFERATION</td><td></td><td>69</td><td>-0.44</td><td>-1.14</td><td>0.333</td><td>0.705</td><td>1.000</td><td>2793</td><td>tags=57%, list=26%, signal=76%</td></tr><tr><td class='lessen'>345</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN</td><td></td><td>18</td><td>-0.54</td><td>-1.14</td><td>0.391</td><td>0.704</td><td>1.000</td><td>4066</td><td>tags=78%, list=37%, signal=124%</td></tr><tr><td class='lessen'>346</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</td><td></td><td>69</td><td>-0.55</td><td>-1.14</td><td>0.462</td><td>0.707</td><td>1.000</td><td>2965</td><td>tags=67%, list=27%, signal=91%</td></tr><tr><td class='lessen'>347</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>267</td><td>-0.23</td><td>-1.14</td><td>0.170</td><td>0.707</td><td>1.000</td><td>2564</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>348</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>92</td><td>-0.31</td><td>-1.14</td><td>0.308</td><td>0.708</td><td>1.000</td><td>1839</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>349</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP</td><td></td><td>61</td><td>-0.37</td><td>-1.14</td><td>0.420</td><td>0.707</td><td>1.000</td><td>1563</td><td>tags=38%, list=14%, signal=44%</td></tr><tr><td class='lessen'>350</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>188</td><td>-0.26</td><td>-1.14</td><td>0.304</td><td>0.707</td><td>1.000</td><td>2181</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>351</td><td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td><td></td><td>241</td><td>-0.33</td><td>-1.14</td><td>0.261</td><td>0.705</td><td>1.000</td><td>3040</td><td>tags=45%, list=28%, signal=61%</td></tr><tr><td class='lessen'>352</td><td>GENTILE_UV_LOW_DOSE_DN</td><td></td><td>39</td><td>-0.32</td><td>-1.14</td><td>0.320</td><td>0.704</td><td>1.000</td><td>2226</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>353</td><td>JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN</td><td></td><td>41</td><td>-0.34</td><td>-1.14</td><td>0.327</td><td>0.703</td><td>1.000</td><td>2041</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>354</td><td>YAGI_AML_WITH_T_9_11_TRANSLOCATION</td><td></td><td>68</td><td>-0.26</td><td>-1.14</td><td>0.193</td><td>0.702</td><td>1.000</td><td>346</td><td>tags=13%, list=3%, signal=14%</td></tr><tr><td class='lessen'>355</td><td>NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON</td><td></td><td>18</td><td>-0.41</td><td>-1.14</td><td>0.300</td><td>0.700</td><td>1.000</td><td>2769</td><td>tags=56%, list=25%, signal=74%</td></tr><tr><td class='lessen'>356</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td><td></td><td>34</td><td>-0.41</td><td>-1.14</td><td>0.340</td><td>0.700</td><td>1.000</td><td>942</td><td>tags=26%, list=9%, signal=29%</td></tr><tr><td class='lessen'>357</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td><td></td><td>45</td><td>-0.31</td><td>-1.14</td><td>0.245</td><td>0.698</td><td>1.000</td><td>2958</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>358</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC</td><td></td><td>23</td><td>-0.35</td><td>-1.14</td><td>0.313</td><td>0.697</td><td>1.000</td><td>2388</td><td>tags=43%, list=22%, signal=56%</td></tr><tr><td class='lessen'>359</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td><td></td><td>380</td><td>-0.26</td><td>-1.14</td><td>0.286</td><td>0.696</td><td>1.000</td><td>2342</td><td>tags=30%, list=22%, signal=37%</td></tr><tr><td class='lessen'>360</td><td>MCLACHLAN_DENTAL_CARIES_DN</td><td></td><td>52</td><td>-0.32</td><td>-1.14</td><td>0.283</td><td>0.696</td><td>1.000</td><td>1000</td><td>tags=23%, list=9%, signal=25%</td></tr><tr><td class='lessen'>361</td><td>BENPORATH_MYC_TARGETS_WITH_EBOX</td><td></td><td>132</td><td>-0.27</td><td>-1.13</td><td>0.280</td><td>0.704</td><td>1.000</td><td>2195</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>362</td><td>LANDIS_BREAST_CANCER_PROGRESSION_UP</td><td></td><td>17</td><td>-0.35</td><td>-1.13</td><td>0.308</td><td>0.703</td><td>1.000</td><td>1409</td><td>tags=35%, list=13%, signal=40%</td></tr><tr><td class='lessen'>363</td><td>GALE_APL_WITH_FLT3_MUTATED_UP</td><td></td><td>23</td><td>-0.35</td><td>-1.13</td><td>0.295</td><td>0.701</td><td>1.000</td><td>1594</td><td>tags=30%, list=15%, signal=36%</td></tr><tr><td class='lessen'>364</td><td>DE_YY1_TARGETS_DN</td><td></td><td>53</td><td>-0.33</td><td>-1.13</td><td>0.314</td><td>0.701</td><td>1.000</td><td>1871</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>365</td><td>LAU_APOPTOSIS_CDKN2A_UP</td><td></td><td>33</td><td>-0.33</td><td>-1.13</td><td>0.340</td><td>0.705</td><td>1.000</td><td>1313</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>366</td><td>CHEN_HOXA5_TARGETS_9HR_DN</td><td></td><td>19</td><td>-0.43</td><td>-1.13</td><td>0.315</td><td>0.705</td><td>1.000</td><td>2091</td><td>tags=47%, list=19%, signal=59%</td></tr><tr><td class='lessen'>367</td><td>BENPORATH_NANOG_TARGETS</td><td></td><td>483</td><td>-0.24</td><td>-1.13</td><td>0.220</td><td>0.709</td><td>1.000</td><td>2097</td><td>tags=28%, list=19%, signal=33%</td></tr><tr><td class='lessen'>368</td><td>NICK_RESPONSE_TO_PROC_TREATMENT_DN</td><td></td><td>15</td><td>-0.43</td><td>-1.12</td><td>0.333</td><td>0.712</td><td>1.000</td><td>2735</td><td>tags=53%, list=25%, signal=71%</td></tr><tr><td class='lessen'>369</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>245</td><td>-0.27</td><td>-1.12</td><td>0.241</td><td>0.711</td><td>1.000</td><td>1877</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>370</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>414</td><td>-0.26</td><td>-1.12</td><td>0.280</td><td>0.711</td><td>1.000</td><td>2585</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>371</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td><td></td><td>51</td><td>-0.28</td><td>-1.12</td><td>0.191</td><td>0.712</td><td>1.000</td><td>2313</td><td>tags=31%, list=21%, signal=40%</td></tr><tr><td class='lessen'>372</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td><td></td><td>164</td><td>-0.24</td><td>-1.12</td><td>0.267</td><td>0.712</td><td>1.000</td><td>2362</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>373</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP</td><td></td><td>17</td><td>-0.41</td><td>-1.12</td><td>0.391</td><td>0.718</td><td>1.000</td><td>1777</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>374</td><td>LEE_EARLY_T_LYMPHOCYTE_UP</td><td></td><td>58</td><td>-0.48</td><td>-1.12</td><td>0.429</td><td>0.717</td><td>1.000</td><td>2156</td><td>tags=52%, list=20%, signal=64%</td></tr><tr><td class='lessen'>375</td><td>RAMASWAMY_METASTASIS_UP</td><td></td><td>28</td><td>-0.39</td><td>-1.12</td><td>0.327</td><td>0.716</td><td>1.000</td><td>2729</td><td>tags=50%, list=25%, signal=67%</td></tr><tr><td class='lessen'>376</td><td>HUANG_DASATINIB_RESISTANCE_DN</td><td></td><td>38</td><td>-0.32</td><td>-1.12</td><td>0.294</td><td>0.715</td><td>1.000</td><td>2252</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>377</td><td>IKEDA_MIR133_TARGETS_UP</td><td></td><td>30</td><td>-0.32</td><td>-1.12</td><td>0.270</td><td>0.718</td><td>1.000</td><td>801</td><td>tags=20%, list=7%, signal=22%</td></tr><tr><td class='lessen'>378</td><td>RAMALHO_STEMNESS_UP</td><td></td><td>112</td><td>-0.29</td><td>-1.11</td><td>0.259</td><td>0.717</td><td>1.000</td><td>2400</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>379</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4</td><td></td><td>108</td><td>-0.25</td><td>-1.11</td><td>0.220</td><td>0.717</td><td>1.000</td><td>2014</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>380</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td><td></td><td>38</td><td>-0.32</td><td>-1.11</td><td>0.208</td><td>0.717</td><td>1.000</td><td>1722</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>381</td><td>AIYAR_COBRA1_TARGETS_DN</td><td></td><td>17</td><td>-0.35</td><td>-1.11</td><td>0.333</td><td>0.716</td><td>1.000</td><td>1523</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>382</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>274</td><td>-0.29</td><td>-1.11</td><td>0.326</td><td>0.719</td><td>1.000</td><td>2331</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>383</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>267</td><td>-0.35</td><td>-1.11</td><td>0.341</td><td>0.719</td><td>1.000</td><td>2745</td><td>tags=43%, list=25%, signal=56%</td></tr><tr><td class='lessen'>384</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>27</td><td>-0.35</td><td>-1.11</td><td>0.271</td><td>0.718</td><td>1.000</td><td>3305</td><td>tags=56%, list=30%, signal=80%</td></tr><tr><td class='lessen'>385</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</td><td></td><td>76</td><td>-0.29</td><td>-1.11</td><td>0.310</td><td>0.717</td><td>1.000</td><td>2059</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>386</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td><td></td><td>178</td><td>-0.29</td><td>-1.11</td><td>0.349</td><td>0.716</td><td>1.000</td><td>2235</td><td>tags=33%, list=21%, signal=40%</td></tr><tr><td class='lessen'>387</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>43</td><td>-0.52</td><td>-1.11</td><td>0.429</td><td>0.717</td><td>1.000</td><td>3120</td><td>tags=65%, list=29%, signal=91%</td></tr><tr><td class='lessen'>388</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td><td></td><td>53</td><td>-0.29</td><td>-1.11</td><td>0.271</td><td>0.717</td><td>1.000</td><td>2795</td><td>tags=40%, list=26%, signal=53%</td></tr><tr><td class='lessen'>389</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN</td><td></td><td>106</td><td>-0.25</td><td>-1.11</td><td>0.271</td><td>0.715</td><td>1.000</td><td>1631</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>390</td><td>DORN_ADENOVIRUS_INFECTION_24HR_DN</td><td></td><td>18</td><td>-0.40</td><td>-1.11</td><td>0.392</td><td>0.715</td><td>1.000</td><td>2134</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>391</td><td>MARTIN_INTERACT_WITH_HDAC</td><td></td><td>24</td><td>-0.41</td><td>-1.11</td><td>0.422</td><td>0.714</td><td>1.000</td><td>3185</td><td>tags=54%, list=29%, signal=76%</td></tr><tr><td class='lessen'>392</td><td>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</td><td></td><td>127</td><td>-0.24</td><td>-1.11</td><td>0.327</td><td>0.716</td><td>1.000</td><td>2097</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>393</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td><td></td><td>79</td><td>-0.28</td><td>-1.11</td><td>0.318</td><td>0.716</td><td>1.000</td><td>1611</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>394</td><td>JAIN_NFKB_SIGNALING</td><td></td><td>36</td><td>-0.29</td><td>-1.11</td><td>0.308</td><td>0.715</td><td>1.000</td><td>3292</td><td>tags=53%, list=30%, signal=75%</td></tr><tr><td class='lessen'>395</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>146</td><td>-0.26</td><td>-1.10</td><td>0.275</td><td>0.716</td><td>1.000</td><td>1796</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>396</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP</td><td></td><td>75</td><td>-0.28</td><td>-1.10</td><td>0.244</td><td>0.714</td><td>1.000</td><td>2188</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>397</td><td>YANG_BREAST_CANCER_ESR1_DN</td><td></td><td>15</td><td>-0.44</td><td>-1.10</td><td>0.320</td><td>0.713</td><td>1.000</td><td>928</td><td>tags=33%, list=9%, signal=36%</td></tr><tr><td class='lessen'>398</td><td>SESTO_RESPONSE_TO_UV_C7</td><td></td><td>34</td><td>-0.31</td><td>-1.10</td><td>0.300</td><td>0.714</td><td>1.000</td><td>2331</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>399</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>110</td><td>-0.25</td><td>-1.10</td><td>0.333</td><td>0.712</td><td>1.000</td><td>2160</td><td>tags=33%, list=20%, signal=40%</td></tr><tr><td class='lessen'>400</td><td>ZWANG_EGF_INTERVAL_UP</td><td></td><td>40</td><td>-0.30</td><td>-1.10</td><td>0.333</td><td>0.713</td><td>1.000</td><td>2937</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>401</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS</td><td></td><td>99</td><td>-0.27</td><td>-1.10</td><td>0.296</td><td>0.712</td><td>1.000</td><td>1667</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>402</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP</td><td></td><td>15</td><td>-0.39</td><td>-1.10</td><td>0.357</td><td>0.711</td><td>1.000</td><td>1772</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>403</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>111</td><td>-0.28</td><td>-1.10</td><td>0.319</td><td>0.709</td><td>1.000</td><td>1681</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>404</td><td>BURTON_ADIPOGENESIS_PEAK_AT_24HR</td><td></td><td>21</td><td>-0.47</td><td>-1.10</td><td>0.391</td><td>0.708</td><td>1.000</td><td>2201</td><td>tags=52%, list=20%, signal=66%</td></tr><tr><td class='lessen'>405</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP</td><td></td><td>40</td><td>-0.29</td><td>-1.10</td><td>0.340</td><td>0.707</td><td>1.000</td><td>1839</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>406</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</td><td></td><td>58</td><td>-0.36</td><td>-1.10</td><td>0.354</td><td>0.706</td><td>1.000</td><td>2174</td><td>tags=43%, list=20%, signal=54%</td></tr><tr><td class='lessen'>407</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>358</td><td>-0.24</td><td>-1.10</td><td>0.271</td><td>0.706</td><td>1.000</td><td>2271</td><td>tags=28%, list=21%, signal=34%</td></tr><tr><td class='lessen'>408</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP</td><td></td><td>54</td><td>-0.28</td><td>-1.10</td><td>0.319</td><td>0.704</td><td>1.000</td><td>2226</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>409</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>18</td><td>-0.35</td><td>-1.10</td><td>0.364</td><td>0.703</td><td>1.000</td><td>1909</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>410</td><td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td><td></td><td>198</td><td>-0.23</td><td>-1.10</td><td>0.233</td><td>0.702</td><td>1.000</td><td>2362</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>411</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP</td><td></td><td>25</td><td>-0.31</td><td>-1.10</td><td>0.327</td><td>0.701</td><td>1.000</td><td>1923</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>412</td><td>CHANGOLKAR_H2AFY_TARGETS_DN</td><td></td><td>21</td><td>-0.36</td><td>-1.10</td><td>0.309</td><td>0.702</td><td>1.000</td><td>986</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>413</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>25</td><td>-0.33</td><td>-1.10</td><td>0.265</td><td>0.702</td><td>1.000</td><td>1795</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>414</td><td>PRAMOONJAGO_SOX4_TARGETS_DN</td><td></td><td>27</td><td>-0.38</td><td>-1.10</td><td>0.362</td><td>0.701</td><td>1.000</td><td>2091</td><td>tags=52%, list=19%, signal=64%</td></tr><tr><td class='lessen'>415</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>252</td><td>-0.29</td><td>-1.10</td><td>0.386</td><td>0.702</td><td>1.000</td><td>2314</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>416</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>37</td><td>-0.33</td><td>-1.09</td><td>0.360</td><td>0.706</td><td>1.000</td><td>3280</td><td>tags=46%, list=30%, signal=66%</td></tr><tr><td class='lessen'>417</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>19</td><td>-0.37</td><td>-1.09</td><td>0.321</td><td>0.705</td><td>1.000</td><td>1863</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>418</td><td>WANG_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>17</td><td>-0.38</td><td>-1.09</td><td>0.326</td><td>0.704</td><td>1.000</td><td>3113</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>419</td><td>LI_DCP2_BOUND_MRNA</td><td></td><td>50</td><td>-0.32</td><td>-1.09</td><td>0.340</td><td>0.703</td><td>1.000</td><td>2757</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>420</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>343</td><td>-0.30</td><td>-1.09</td><td>0.298</td><td>0.702</td><td>1.000</td><td>2933</td><td>tags=43%, list=27%, signal=56%</td></tr><tr><td class='lessen'>421</td><td>BROWNE_HCMV_INFECTION_12HR_DN</td><td></td><td>57</td><td>-0.28</td><td>-1.09</td><td>0.325</td><td>0.704</td><td>1.000</td><td>2327</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>422</td><td>GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION</td><td></td><td>20</td><td>-0.36</td><td>-1.09</td><td>0.407</td><td>0.704</td><td>1.000</td><td>1062</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>423</td><td>WANG_TUMOR_INVASIVENESS_DN</td><td></td><td>125</td><td>-0.23</td><td>-1.09</td><td>0.315</td><td>0.709</td><td>1.000</td><td>1988</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>424</td><td>COLDREN_GEFITINIB_RESISTANCE_UP</td><td></td><td>40</td><td>-0.36</td><td>-1.09</td><td>0.354</td><td>0.708</td><td>1.000</td><td>2003</td><td>tags=38%, list=18%, signal=46%</td></tr><tr><td class='lessen'>425</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td><td></td><td>118</td><td>-0.25</td><td>-1.09</td><td>0.288</td><td>0.708</td><td>1.000</td><td>2165</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>426</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</td><td></td><td>46</td><td>-0.27</td><td>-1.09</td><td>0.347</td><td>0.708</td><td>1.000</td><td>2037</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>427</td><td>GEISS_RESPONSE_TO_DSRNA_UP</td><td></td><td>18</td><td>-0.37</td><td>-1.09</td><td>0.357</td><td>0.708</td><td>1.000</td><td>1094</td><td>tags=33%, list=10%, signal=37%</td></tr><tr><td class='lessen'>428</td><td>NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON</td><td></td><td>19</td><td>-0.36</td><td>-1.09</td><td>0.315</td><td>0.708</td><td>1.000</td><td>3227</td><td>tags=58%, list=30%, signal=82%</td></tr><tr><td class='lessen'>429</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>295</td><td>-0.25</td><td>-1.08</td><td>0.328</td><td>0.708</td><td>1.000</td><td>1776</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>430</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>446</td><td>-0.25</td><td>-1.08</td><td>0.298</td><td>0.707</td><td>1.000</td><td>3031</td><td>tags=40%, list=28%, signal=54%</td></tr><tr><td class='lessen'>431</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>103</td><td>-0.30</td><td>-1.08</td><td>0.333</td><td>0.707</td><td>1.000</td><td>1603</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>432</td><td>ULE_SPLICING_VIA_NOVA2</td><td></td><td>29</td><td>-0.30</td><td>-1.08</td><td>0.320</td><td>0.705</td><td>1.000</td><td>1357</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>433</td><td>SERVITJA_LIVER_HNF1A_TARGETS_UP</td><td></td><td>83</td><td>-0.27</td><td>-1.08</td><td>0.262</td><td>0.705</td><td>1.000</td><td>1253</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>434</td><td>BAKKER_FOXO3_TARGETS_DN</td><td></td><td>98</td><td>-0.26</td><td>-1.08</td><td>0.333</td><td>0.704</td><td>1.000</td><td>1070</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>435</td><td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td><td></td><td>23</td><td>-0.37</td><td>-1.08</td><td>0.341</td><td>0.702</td><td>1.000</td><td>2729</td><td>tags=35%, list=25%, signal=46%</td></tr><tr><td class='lessen'>436</td><td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td><td></td><td>34</td><td>-0.35</td><td>-1.08</td><td>0.426</td><td>0.702</td><td>1.000</td><td>1948</td><td>tags=35%, list=18%, signal=43%</td></tr><tr><td class='lessen'>437</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</td><td></td><td>168</td><td>-0.30</td><td>-1.08</td><td>0.404</td><td>0.703</td><td>1.000</td><td>2512</td><td>tags=40%, list=23%, signal=51%</td></tr><tr><td class='lessen'>438</td><td>HUANG_FOXA2_TARGETS_UP</td><td></td><td>24</td><td>-0.31</td><td>-1.08</td><td>0.314</td><td>0.702</td><td>1.000</td><td>1848</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>439</td><td>PENG_GLUCOSE_DEPRIVATION_DN</td><td></td><td>86</td><td>-0.25</td><td>-1.08</td><td>0.346</td><td>0.701</td><td>1.000</td><td>1724</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>440</td><td>DELACROIX_RAR_TARGETS_DN</td><td></td><td>16</td><td>-0.36</td><td>-1.08</td><td>0.389</td><td>0.700</td><td>1.000</td><td>2059</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>441</td><td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP</td><td></td><td>15</td><td>-0.41</td><td>-1.08</td><td>0.407</td><td>0.700</td><td>1.000</td><td>1750</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>442</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>278</td><td>-0.22</td><td>-1.08</td><td>0.319</td><td>0.698</td><td>1.000</td><td>2534</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>443</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</td><td></td><td>22</td><td>-0.36</td><td>-1.08</td><td>0.360</td><td>0.697</td><td>1.000</td><td>3112</td><td>tags=45%, list=29%, signal=64%</td></tr><tr><td class='lessen'>444</td><td>OLSSON_E2F3_TARGETS_DN</td><td></td><td>24</td><td>-0.35</td><td>-1.08</td><td>0.346</td><td>0.698</td><td>1.000</td><td>2133</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>445</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>166</td><td>-0.29</td><td>-1.08</td><td>0.354</td><td>0.697</td><td>1.000</td><td>2284</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>446</td><td>LY_AGING_PREMATURE_DN</td><td></td><td>17</td><td>-0.50</td><td>-1.08</td><td>0.386</td><td>0.697</td><td>1.000</td><td>2177</td><td>tags=47%, list=20%, signal=59%</td></tr><tr><td class='lessen'>447</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>31</td><td>-0.30</td><td>-1.08</td><td>0.349</td><td>0.696</td><td>1.000</td><td>1019</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>448</td><td>WILLIAMS_ESR1_TARGETS_UP</td><td></td><td>16</td><td>-0.41</td><td>-1.08</td><td>0.417</td><td>0.698</td><td>1.000</td><td>3269</td><td>tags=63%, list=30%, signal=89%</td></tr><tr><td class='lessen'>449</td><td>SMITH_LIVER_CANCER</td><td></td><td>26</td><td>-0.32</td><td>-1.08</td><td>0.308</td><td>0.697</td><td>1.000</td><td>2269</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>450</td><td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td><td></td><td>267</td><td>-0.31</td><td>-1.08</td><td>0.364</td><td>0.698</td><td>1.000</td><td>2824</td><td>tags=42%, list=26%, signal=55%</td></tr><tr><td class='lessen'>451</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td><td></td><td>425</td><td>-0.24</td><td>-1.08</td><td>0.320</td><td>0.697</td><td>1.000</td><td>1804</td><td>tags=26%, list=17%, signal=30%</td></tr><tr><td class='lessen'>452</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN</td><td></td><td>24</td><td>-0.33</td><td>-1.07</td><td>0.340</td><td>0.699</td><td>1.000</td><td>3131</td><td>tags=42%, list=29%, signal=58%</td></tr><tr><td class='lessen'>453</td><td>BENPORATH_ES_CORE_NINE_CORRELATED</td><td></td><td>48</td><td>-0.31</td><td>-1.07</td><td>0.366</td><td>0.700</td><td>1.000</td><td>2347</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>454</td><td>ZHENG_IL22_SIGNALING_DN</td><td></td><td>25</td><td>-0.38</td><td>-1.07</td><td>0.444</td><td>0.699</td><td>1.000</td><td>2615</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>455</td><td>TOOKER_GEMCITABINE_RESISTANCE_DN</td><td></td><td>72</td><td>-0.29</td><td>-1.07</td><td>0.365</td><td>0.699</td><td>1.000</td><td>2082</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>456</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td><td></td><td>58</td><td>-0.28</td><td>-1.07</td><td>0.313</td><td>0.699</td><td>1.000</td><td>643</td><td>tags=16%, list=6%, signal=16%</td></tr><tr><td class='lessen'>457</td><td>CHANG_CYCLING_GENES</td><td></td><td>68</td><td>-0.46</td><td>-1.07</td><td>0.439</td><td>0.704</td><td>1.000</td><td>2146</td><td>tags=47%, list=20%, signal=58%</td></tr><tr><td class='lessen'>458</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP</td><td></td><td>82</td><td>-0.26</td><td>-1.07</td><td>0.313</td><td>0.704</td><td>1.000</td><td>2188</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>459</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_DN</td><td></td><td>103</td><td>-0.27</td><td>-1.07</td><td>0.340</td><td>0.703</td><td>1.000</td><td>2496</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>460</td><td>BROWNE_HCMV_INFECTION_16HR_DN</td><td></td><td>45</td><td>-0.29</td><td>-1.07</td><td>0.333</td><td>0.706</td><td>1.000</td><td>2466</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>461</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>17</td><td>-0.34</td><td>-1.07</td><td>0.358</td><td>0.705</td><td>1.000</td><td>3064</td><td>tags=53%, list=28%, signal=74%</td></tr><tr><td class='lessen'>462</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN</td><td></td><td>23</td><td>-0.35</td><td>-1.07</td><td>0.469</td><td>0.704</td><td>1.000</td><td>3468</td><td>tags=57%, list=32%, signal=83%</td></tr><tr><td class='lessen'>463</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN</td><td></td><td>28</td><td>-0.45</td><td>-1.07</td><td>0.444</td><td>0.703</td><td>1.000</td><td>3629</td><td>tags=68%, list=33%, signal=102%</td></tr><tr><td class='lessen'>464</td><td>HUMMEL_BURKITTS_LYMPHOMA_UP</td><td></td><td>19</td><td>-0.40</td><td>-1.06</td><td>0.396</td><td>0.702</td><td>1.000</td><td>2097</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>465</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_DN</td><td></td><td>106</td><td>-0.23</td><td>-1.06</td><td>0.340</td><td>0.704</td><td>1.000</td><td>1904</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>466</td><td>SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN</td><td></td><td>30</td><td>-0.29</td><td>-1.06</td><td>0.345</td><td>0.704</td><td>1.000</td><td>1221</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>467</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>228</td><td>-0.22</td><td>-1.06</td><td>0.293</td><td>0.704</td><td>1.000</td><td>2016</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>468</td><td>KIM_MYC_AMPLIFICATION_TARGETS_UP</td><td></td><td>97</td><td>-0.25</td><td>-1.06</td><td>0.352</td><td>0.703</td><td>1.000</td><td>2181</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>469</td><td>LEI_MYB_TARGETS</td><td></td><td>177</td><td>-0.25</td><td>-1.06</td><td>0.429</td><td>0.703</td><td>1.000</td><td>2257</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>470</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_UP</td><td></td><td>83</td><td>-0.33</td><td>-1.06</td><td>0.476</td><td>0.703</td><td>1.000</td><td>2241</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>471</td><td>MAYBURD_RESPONSE_TO_L663536_UP</td><td></td><td>19</td><td>-0.36</td><td>-1.06</td><td>0.347</td><td>0.702</td><td>1.000</td><td>558</td><td>tags=21%, list=5%, signal=22%</td></tr><tr><td class='lessen'>472</td><td>DOANE_BREAST_CANCER_ESR1_UP</td><td></td><td>58</td><td>-0.30</td><td>-1.06</td><td>0.396</td><td>0.703</td><td>1.000</td><td>1574</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>473</td><td>KIM_TIAL1_TARGETS</td><td></td><td>22</td><td>-0.36</td><td>-1.06</td><td>0.421</td><td>0.701</td><td>1.000</td><td>2194</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>474</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td><td></td><td>58</td><td>-0.27</td><td>-1.06</td><td>0.327</td><td>0.701</td><td>1.000</td><td>1728</td><td>tags=22%, list=16%, signal=27%</td></tr><tr><td class='lessen'>475</td><td>ZHAN_MULTIPLE_MYELOMA_UP</td><td></td><td>38</td><td>-0.29</td><td>-1.06</td><td>0.358</td><td>0.700</td><td>1.000</td><td>1882</td><td>tags=34%, list=17%, signal=41%</td></tr><tr><td class='lessen'>476</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</td><td></td><td>21</td><td>-0.37</td><td>-1.06</td><td>0.392</td><td>0.699</td><td>1.000</td><td>2311</td><td>tags=43%, list=21%, signal=54%</td></tr><tr><td class='lessen'>477</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>186</td><td>-0.23</td><td>-1.06</td><td>0.326</td><td>0.701</td><td>1.000</td><td>2707</td><td>tags=34%, list=25%, signal=44%</td></tr><tr><td class='lessen'>478</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>214</td><td>-0.25</td><td>-1.06</td><td>0.365</td><td>0.705</td><td>1.000</td><td>1718</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>479</td><td>MURATA_VIRULENCE_OF_H_PILORI</td><td></td><td>20</td><td>-0.41</td><td>-1.06</td><td>0.455</td><td>0.705</td><td>1.000</td><td>2571</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>480</td><td>DOANE_BREAST_CANCER_CLASSES_UP</td><td></td><td>37</td><td>-0.31</td><td>-1.05</td><td>0.377</td><td>0.704</td><td>1.000</td><td>2291</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>481</td><td>PARK_HSC_MARKERS</td><td></td><td>21</td><td>-0.35</td><td>-1.05</td><td>0.386</td><td>0.708</td><td>1.000</td><td>1593</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>482</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>136</td><td>-0.27</td><td>-1.05</td><td>0.356</td><td>0.708</td><td>1.000</td><td>2037</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>483</td><td>ZHOU_TNF_SIGNALING_30MIN</td><td></td><td>24</td><td>-0.33</td><td>-1.05</td><td>0.386</td><td>0.708</td><td>1.000</td><td>1773</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>484</td><td>KORKOLA_CORRELATED_WITH_POU5F1</td><td></td><td>15</td><td>-0.41</td><td>-1.05</td><td>0.396</td><td>0.707</td><td>1.000</td><td>2664</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>485</td><td>FUJII_YBX1_TARGETS_UP</td><td></td><td>23</td><td>-0.32</td><td>-1.05</td><td>0.340</td><td>0.707</td><td>1.000</td><td>2567</td><td>tags=43%, list=24%, signal=57%</td></tr><tr><td class='lessen'>486</td><td>PIONTEK_PKD1_TARGETS_UP</td><td></td><td>16</td><td>-0.37</td><td>-1.05</td><td>0.321</td><td>0.707</td><td>1.000</td><td>1270</td><td>tags=31%, list=12%, signal=35%</td></tr><tr><td class='lessen'>487</td><td>LU_AGING_BRAIN_DN</td><td></td><td>90</td><td>-0.26</td><td>-1.05</td><td>0.386</td><td>0.709</td><td>1.000</td><td>3116</td><td>tags=43%, list=29%, signal=60%</td></tr><tr><td class='lessen'>488</td><td>FERNANDEZ_BOUND_BY_MYC</td><td></td><td>113</td><td>-0.27</td><td>-1.05</td><td>0.435</td><td>0.708</td><td>1.000</td><td>2484</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>489</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_DN</td><td></td><td>114</td><td>-0.25</td><td>-1.05</td><td>0.343</td><td>0.708</td><td>1.000</td><td>2261</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>490</td><td>VANTVEER_BREAST_CANCER_METASTASIS_DN</td><td></td><td>55</td><td>-0.39</td><td>-1.05</td><td>0.444</td><td>0.707</td><td>1.000</td><td>2820</td><td>tags=51%, list=26%, signal=68%</td></tr><tr><td class='lessen'>491</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP</td><td></td><td>24</td><td>-0.32</td><td>-1.05</td><td>0.462</td><td>0.706</td><td>1.000</td><td>1913</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>492</td><td>AMIT_EGF_RESPONSE_40_HELA</td><td></td><td>21</td><td>-0.39</td><td>-1.05</td><td>0.446</td><td>0.708</td><td>1.000</td><td>2261</td><td>tags=48%, list=21%, signal=60%</td></tr><tr><td class='lessen'>493</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</td><td></td><td>27</td><td>-0.48</td><td>-1.05</td><td>0.512</td><td>0.708</td><td>1.000</td><td>2176</td><td>tags=56%, list=20%, signal=69%</td></tr><tr><td class='lessen'>494</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>58</td><td>-0.27</td><td>-1.04</td><td>0.418</td><td>0.707</td><td>1.000</td><td>963</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>495</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>216</td><td>-0.21</td><td>-1.04</td><td>0.373</td><td>0.708</td><td>1.000</td><td>1881</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>496</td><td>FRASOR_TAMOXIFEN_RESPONSE_UP</td><td></td><td>29</td><td>-0.32</td><td>-1.04</td><td>0.441</td><td>0.708</td><td>1.000</td><td>1713</td><td>tags=34%, list=16%, signal=41%</td></tr><tr><td class='lessen'>497</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>107</td><td>-0.25</td><td>-1.04</td><td>0.372</td><td>0.710</td><td>1.000</td><td>2619</td><td>tags=36%, list=24%, signal=48%</td></tr><tr><td class='lessen'>498</td><td>KORKOLA_TERATOMA</td><td></td><td>21</td><td>-0.33</td><td>-1.04</td><td>0.373</td><td>0.709</td><td>1.000</td><td>3120</td><td>tags=48%, list=29%, signal=67%</td></tr><tr><td class='lessen'>499</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>193</td><td>-0.25</td><td>-1.04</td><td>0.345</td><td>0.709</td><td>1.000</td><td>2629</td><td>tags=33%, list=24%, signal=42%</td></tr><tr><td class='lessen'>500</td><td>DARWICHE_PAPILLOMA_RISK_LOW_DN</td><td></td><td>76</td><td>-0.25</td><td>-1.04</td><td>0.375</td><td>0.710</td><td>1.000</td><td>1611</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>501</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td><td></td><td>449</td><td>-0.24</td><td>-1.04</td><td>0.393</td><td>0.710</td><td>1.000</td><td>2258</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>502</td><td>KARLSSON_TGFB1_TARGETS_UP</td><td></td><td>58</td><td>-0.31</td><td>-1.04</td><td>0.362</td><td>0.709</td><td>1.000</td><td>2614</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>503</td><td>SABATES_COLORECTAL_ADENOMA_UP</td><td></td><td>74</td><td>-0.30</td><td>-1.04</td><td>0.388</td><td>0.709</td><td>1.000</td><td>3426</td><td>tags=45%, list=31%, signal=65%</td></tr><tr><td class='lessen'>504</td><td>LIU_PROSTATE_CANCER_UP</td><td></td><td>43</td><td>-0.31</td><td>-1.04</td><td>0.429</td><td>0.708</td><td>1.000</td><td>3922</td><td>tags=58%, list=36%, signal=91%</td></tr><tr><td class='lessen'>505</td><td>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN</td><td></td><td>16</td><td>-0.35</td><td>-1.04</td><td>0.409</td><td>0.709</td><td>1.000</td><td>2450</td><td>tags=50%, list=23%, signal=64%</td></tr><tr><td class='lessen'>506</td><td>BROWNE_HCMV_INFECTION_4HR_DN</td><td></td><td>156</td><td>-0.22</td><td>-1.04</td><td>0.349</td><td>0.708</td><td>1.000</td><td>2239</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>507</td><td>LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q</td><td></td><td>69</td><td>-0.25</td><td>-1.04</td><td>0.333</td><td>0.709</td><td>1.000</td><td>2483</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>508</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>250</td><td>-0.21</td><td>-1.04</td><td>0.360</td><td>0.708</td><td>1.000</td><td>1468</td><td>tags=18%, list=13%, signal=21%</td></tr><tr><td class='lessen'>509</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>36</td><td>-0.29</td><td>-1.03</td><td>0.373</td><td>0.710</td><td>1.000</td><td>1162</td><td>tags=19%, list=11%, signal=22%</td></tr><tr><td class='lessen'>510</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>191</td><td>-0.23</td><td>-1.03</td><td>0.391</td><td>0.710</td><td>1.000</td><td>1370</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>511</td><td>ZHAN_EARLY_DIFFERENTIATION_GENES_DN</td><td></td><td>23</td><td>-0.35</td><td>-1.03</td><td>0.386</td><td>0.710</td><td>1.000</td><td>1770</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>512</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>34</td><td>-0.36</td><td>-1.03</td><td>0.373</td><td>0.709</td><td>1.000</td><td>2565</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>513</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_7</td><td></td><td>24</td><td>-0.34</td><td>-1.03</td><td>0.404</td><td>0.708</td><td>1.000</td><td>1801</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>514</td><td>JACKSON_DNMT1_TARGETS_DN</td><td></td><td>21</td><td>-0.33</td><td>-1.03</td><td>0.392</td><td>0.708</td><td>1.000</td><td>3325</td><td>tags=38%, list=31%, signal=55%</td></tr><tr><td class='lessen'>515</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>105</td><td>-0.24</td><td>-1.03</td><td>0.442</td><td>0.707</td><td>1.000</td><td>2223</td><td>tags=34%, list=20%, signal=43%</td></tr><tr><td class='lessen'>516</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_DN</td><td></td><td>68</td><td>-0.25</td><td>-1.03</td><td>0.407</td><td>0.707</td><td>1.000</td><td>1744</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>517</td><td>HOEBEKE_LYMPHOID_STEM_CELL_UP</td><td></td><td>55</td><td>-0.30</td><td>-1.03</td><td>0.400</td><td>0.706</td><td>1.000</td><td>1316</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>518</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td><td></td><td>285</td><td>-0.28</td><td>-1.03</td><td>0.400</td><td>0.707</td><td>1.000</td><td>1489</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>519</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td><td></td><td>412</td><td>-0.23</td><td>-1.03</td><td>0.362</td><td>0.707</td><td>1.000</td><td>2258</td><td>tags=29%, list=21%, signal=35%</td></tr><tr><td class='lessen'>520</td><td>CHENG_RESPONSE_TO_NICKEL_ACETATE</td><td></td><td>22</td><td>-0.29</td><td>-1.03</td><td>0.429</td><td>0.706</td><td>1.000</td><td>1271</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>521</td><td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN</td><td></td><td>23</td><td>-0.53</td><td>-1.03</td><td>0.500</td><td>0.707</td><td>1.000</td><td>2008</td><td>tags=52%, list=18%, signal=64%</td></tr><tr><td class='lessen'>522</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>20</td><td>-0.38</td><td>-1.03</td><td>0.462</td><td>0.708</td><td>1.000</td><td>2201</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>523</td><td>THEODOROU_MAMMARY_TUMORIGENESIS</td><td></td><td>20</td><td>-0.33</td><td>-1.03</td><td>0.458</td><td>0.707</td><td>1.000</td><td>184</td><td>tags=15%, list=2%, signal=15%</td></tr><tr><td class='lessen'>524</td><td>DORN_ADENOVIRUS_INFECTION_48HR_DN</td><td></td><td>15</td><td>-0.43</td><td>-1.03</td><td>0.417</td><td>0.710</td><td>1.000</td><td>2134</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>525</td><td>KIM_WT1_TARGETS_8HR_DN</td><td></td><td>78</td><td>-0.23</td><td>-1.02</td><td>0.395</td><td>0.710</td><td>1.000</td><td>2308</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>526</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td><td></td><td>35</td><td>-0.30</td><td>-1.02</td><td>0.333</td><td>0.714</td><td>1.000</td><td>410</td><td>tags=14%, list=4%, signal=15%</td></tr><tr><td class='lessen'>527</td><td>LI_PROSTATE_CANCER_EPIGENETIC</td><td></td><td>20</td><td>-0.33</td><td>-1.02</td><td>0.500</td><td>0.713</td><td>1.000</td><td>1127</td><td>tags=30%, list=10%, signal=33%</td></tr><tr><td class='lessen'>528</td><td>PARENT_MTOR_SIGNALING_DN</td><td></td><td>27</td><td>-0.33</td><td>-1.02</td><td>0.404</td><td>0.721</td><td>1.000</td><td>3105</td><td>tags=52%, list=29%, signal=72%</td></tr><tr><td class='lessen'>529</td><td>BOYLAN_MULTIPLE_MYELOMA_C_UP</td><td></td><td>24</td><td>-0.30</td><td>-1.02</td><td>0.429</td><td>0.720</td><td>1.000</td><td>2219</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>530</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>41</td><td>-0.29</td><td>-1.02</td><td>0.418</td><td>0.720</td><td>1.000</td><td>2134</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>531</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP</td><td></td><td>45</td><td>-0.29</td><td>-1.02</td><td>0.500</td><td>0.719</td><td>1.000</td><td>1822</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>532</td><td>MARSON_BOUND_BY_E2F4_UNSTIMULATED</td><td></td><td>311</td><td>-0.28</td><td>-1.02</td><td>0.478</td><td>0.719</td><td>1.000</td><td>2233</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>533</td><td>WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2</td><td></td><td>18</td><td>-0.32</td><td>-1.02</td><td>0.356</td><td>0.720</td><td>1.000</td><td>643</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>534</td><td>BASSO_B_LYMPHOCYTE_NETWORK</td><td></td><td>64</td><td>-0.28</td><td>-1.02</td><td>0.449</td><td>0.719</td><td>1.000</td><td>2621</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>535</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</td><td></td><td>125</td><td>-0.26</td><td>-1.02</td><td>0.469</td><td>0.719</td><td>1.000</td><td>2435</td><td>tags=34%, list=22%, signal=43%</td></tr><tr><td class='lessen'>536</td><td>OUILLETTE_CLL_13Q14_DELETION_DN</td><td></td><td>32</td><td>-0.27</td><td>-1.02</td><td>0.415</td><td>0.719</td><td>1.000</td><td>1429</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>537</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>111</td><td>-0.29</td><td>-1.01</td><td>0.438</td><td>0.718</td><td>1.000</td><td>2070</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>538</td><td>RODRIGUES_DCC_TARGETS_DN</td><td></td><td>76</td><td>-0.24</td><td>-1.01</td><td>0.431</td><td>0.717</td><td>1.000</td><td>1720</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>539</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>313</td><td>-0.26</td><td>-1.01</td><td>0.417</td><td>0.716</td><td>1.000</td><td>1938</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>540</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP</td><td></td><td>46</td><td>-0.26</td><td>-1.01</td><td>0.321</td><td>0.716</td><td>1.000</td><td>2223</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>541</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_UP</td><td></td><td>24</td><td>-0.31</td><td>-1.01</td><td>0.442</td><td>0.715</td><td>1.000</td><td>221</td><td>tags=8%, list=2%, signal=8%</td></tr><tr><td class='lessen'>542</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_UP</td><td></td><td>23</td><td>-0.31</td><td>-1.01</td><td>0.382</td><td>0.715</td><td>1.000</td><td>1923</td><td>tags=39%, list=18%, signal=47%</td></tr><tr><td class='lessen'>543</td><td>ODONNELL_METASTASIS_DN</td><td></td><td>15</td><td>-0.40</td><td>-1.01</td><td>0.426</td><td>0.717</td><td>1.000</td><td>2004</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>544</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>147</td><td>-0.31</td><td>-1.01</td><td>0.524</td><td>0.716</td><td>1.000</td><td>2491</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>545</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</td><td></td><td>19</td><td>-0.36</td><td>-1.01</td><td>0.421</td><td>0.716</td><td>1.000</td><td>3140</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>546</td><td>WHITFIELD_CELL_CYCLE_S</td><td></td><td>70</td><td>-0.32</td><td>-1.01</td><td>0.444</td><td>0.716</td><td>1.000</td><td>2439</td><td>tags=44%, list=22%, signal=57%</td></tr><tr><td class='lessen'>547</td><td>SPIRA_SMOKERS_LUNG_CANCER_UP</td><td></td><td>27</td><td>-0.36</td><td>-1.01</td><td>0.407</td><td>0.717</td><td>1.000</td><td>1615</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>548</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP</td><td></td><td>25</td><td>-0.34</td><td>-1.01</td><td>0.367</td><td>0.716</td><td>1.000</td><td>1937</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>549</td><td>GENTILE_UV_RESPONSE_CLUSTER_D2</td><td></td><td>21</td><td>-0.36</td><td>-1.01</td><td>0.426</td><td>0.717</td><td>1.000</td><td>3333</td><td>tags=48%, list=31%, signal=69%</td></tr><tr><td class='lessen'>550</td><td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td><td></td><td>37</td><td>-0.32</td><td>-1.01</td><td>0.523</td><td>0.716</td><td>1.000</td><td>2728</td><td>tags=46%, list=25%, signal=61%</td></tr><tr><td class='lessen'>551</td><td>NUYTTEN_EZH2_TARGETS_DN</td><td></td><td>472</td><td>-0.27</td><td>-1.01</td><td>0.465</td><td>0.718</td><td>1.000</td><td>2933</td><td>tags=40%, list=27%, signal=52%</td></tr><tr><td class='lessen'>552</td><td>BAE_BRCA1_TARGETS_DN</td><td></td><td>17</td><td>-0.31</td><td>-1.01</td><td>0.441</td><td>0.717</td><td>1.000</td><td>3122</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>553</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>171</td><td>-0.21</td><td>-1.01</td><td>0.500</td><td>0.716</td><td>1.000</td><td>2162</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>554</td><td>WANG_LSD1_TARGETS_DN</td><td></td><td>16</td><td>-0.32</td><td>-1.01</td><td>0.407</td><td>0.717</td><td>1.000</td><td>1466</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>555</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_UP</td><td></td><td>18</td><td>-0.34</td><td>-1.00</td><td>0.436</td><td>0.717</td><td>1.000</td><td>1904</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>556</td><td>RIZKI_TUMOR_INVASIVENESS_3D_UP</td><td></td><td>116</td><td>-0.23</td><td>-1.00</td><td>0.455</td><td>0.721</td><td>1.000</td><td>2257</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>557</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td><td></td><td>24</td><td>-0.30</td><td>-1.00</td><td>0.571</td><td>0.721</td><td>1.000</td><td>2295</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>558</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN</td><td></td><td>22</td><td>-0.34</td><td>-1.00</td><td>0.489</td><td>0.720</td><td>1.000</td><td>2574</td><td>tags=41%, list=24%, signal=53%</td></tr><tr><td class='lessen'>559</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN</td><td></td><td>25</td><td>-0.39</td><td>-1.00</td><td>0.500</td><td>0.719</td><td>1.000</td><td>2728</td><td>tags=52%, list=25%, signal=69%</td></tr><tr><td class='lessen'>560</td><td>KUMAR_AUTOPHAGY_NETWORK</td><td></td><td>30</td><td>-0.27</td><td>-1.00</td><td>0.400</td><td>0.717</td><td>1.000</td><td>1741</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>561</td><td>DARWICHE_PAPILLOMA_RISK_LOW_UP</td><td></td><td>63</td><td>-0.25</td><td>-1.00</td><td>0.449</td><td>0.717</td><td>1.000</td><td>1646</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>562</td><td>BURTON_ADIPOGENESIS_PEAK_AT_16HR</td><td></td><td>22</td><td>-0.40</td><td>-1.00</td><td>0.488</td><td>0.717</td><td>1.000</td><td>1960</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>563</td><td>GUO_HEX_TARGETS_UP</td><td></td><td>46</td><td>-0.27</td><td>-1.00</td><td>0.429</td><td>0.717</td><td>1.000</td><td>2120</td><td>tags=30%, list=19%, signal=38%</td></tr><tr><td class='lessen'>564</td><td>BROWNE_HCMV_INFECTION_6HR_DN</td><td></td><td>80</td><td>-0.25</td><td>-1.00</td><td>0.489</td><td>0.716</td><td>1.000</td><td>2195</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>565</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_UP</td><td></td><td>43</td><td>-0.28</td><td>-1.00</td><td>0.463</td><td>0.715</td><td>1.000</td><td>1646</td><td>tags=33%, list=15%, signal=38%</td></tr><tr><td class='lessen'>566</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP</td><td></td><td>21</td><td>-0.34</td><td>-1.00</td><td>0.490</td><td>0.714</td><td>1.000</td><td>2201</td><td>tags=38%, list=20%, signal=48%</td></tr><tr><td class='lessen'>567</td><td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</td><td></td><td>27</td><td>-0.29</td><td>-1.00</td><td>0.458</td><td>0.715</td><td>1.000</td><td>1114</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>568</td><td>RICKMAN_HEAD_AND_NECK_CANCER_A</td><td></td><td>46</td><td>-0.32</td><td>-1.00</td><td>0.522</td><td>0.717</td><td>1.000</td><td>1778</td><td>tags=28%, list=16%, signal=34%</td></tr><tr><td class='lessen'>569</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>37</td><td>-0.28</td><td>-1.00</td><td>0.446</td><td>0.716</td><td>1.000</td><td>2550</td><td>tags=35%, list=23%, signal=46%</td></tr><tr><td class='lessen'>570</td><td>RAO_BOUND_BY_SALL4</td><td></td><td>105</td><td>-0.25</td><td>-1.00</td><td>0.380</td><td>0.715</td><td>1.000</td><td>1769</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>571</td><td>AFFAR_YY1_TARGETS_DN</td><td></td><td>124</td><td>-0.28</td><td>-1.00</td><td>0.447</td><td>0.715</td><td>1.000</td><td>2027</td><td>tags=30%, list=19%, signal=36%</td></tr><tr><td class='lessen'>572</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN</td><td></td><td>50</td><td>-0.29</td><td>-0.99</td><td>0.500</td><td>0.723</td><td>1.000</td><td>1039</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>573</td><td>BRUINS_UVC_RESPONSE_MIDDLE</td><td></td><td>40</td><td>-0.28</td><td>-0.99</td><td>0.447</td><td>0.728</td><td>1.000</td><td>2590</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>574</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>19</td><td>-0.34</td><td>-0.99</td><td>0.523</td><td>0.727</td><td>1.000</td><td>4136</td><td>tags=68%, list=38%, signal=110%</td></tr><tr><td class='lessen'>575</td><td>BROWNE_HCMV_INFECTION_24HR_UP</td><td></td><td>81</td><td>-0.25</td><td>-0.99</td><td>0.407</td><td>0.728</td><td>1.000</td><td>3011</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>576</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>20</td><td>-0.32</td><td>-0.99</td><td>0.489</td><td>0.727</td><td>1.000</td><td>2498</td><td>tags=45%, list=23%, signal=58%</td></tr><tr><td class='lessen'>577</td><td>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</td><td></td><td>15</td><td>-0.35</td><td>-0.99</td><td>0.488</td><td>0.727</td><td>1.000</td><td>1433</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>578</td><td>HOWLIN_CITED1_TARGETS_1_UP</td><td></td><td>18</td><td>-0.34</td><td>-0.99</td><td>0.491</td><td>0.727</td><td>1.000</td><td>3145</td><td>tags=44%, list=29%, signal=62%</td></tr><tr><td class='lessen'>579</td><td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td><td></td><td>24</td><td>-0.31</td><td>-0.99</td><td>0.439</td><td>0.726</td><td>1.000</td><td>1847</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>580</td><td>DOUGLAS_BMI1_TARGETS_UP</td><td></td><td>280</td><td>-0.21</td><td>-0.99</td><td>0.451</td><td>0.725</td><td>1.000</td><td>2277</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>581</td><td>HORIUCHI_WTAP_TARGETS_DN</td><td></td><td>150</td><td>-0.33</td><td>-0.99</td><td>0.533</td><td>0.724</td><td>1.000</td><td>2176</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>582</td><td>ODONNELL_TFRC_TARGETS_DN</td><td></td><td>69</td><td>-0.37</td><td>-0.99</td><td>0.488</td><td>0.725</td><td>1.000</td><td>2820</td><td>tags=43%, list=26%, signal=58%</td></tr><tr><td class='lessen'>583</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>43</td><td>-0.28</td><td>-0.99</td><td>0.465</td><td>0.727</td><td>1.000</td><td>2882</td><td>tags=42%, list=26%, signal=57%</td></tr><tr><td class='lessen'>584</td><td>LY_AGING_OLD_DN</td><td></td><td>33</td><td>-0.44</td><td>-0.98</td><td>0.476</td><td>0.728</td><td>1.000</td><td>2177</td><td>tags=45%, list=20%, signal=57%</td></tr><tr><td class='lessen'>585</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td><td></td><td>141</td><td>-0.22</td><td>-0.98</td><td>0.490</td><td>0.728</td><td>1.000</td><td>2479</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>586</td><td>BASAKI_YBX1_TARGETS_UP</td><td></td><td>140</td><td>-0.29</td><td>-0.98</td><td>0.447</td><td>0.728</td><td>1.000</td><td>2201</td><td>tags=34%, list=20%, signal=42%</td></tr><tr><td class='lessen'>587</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td><td></td><td>47</td><td>-0.29</td><td>-0.98</td><td>0.408</td><td>0.727</td><td>1.000</td><td>1411</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>588</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>139</td><td>-0.25</td><td>-0.98</td><td>0.458</td><td>0.729</td><td>1.000</td><td>1887</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>589</td><td>WEINMANN_ADAPTATION_TO_HYPOXIA_UP</td><td></td><td>16</td><td>-0.31</td><td>-0.98</td><td>0.463</td><td>0.731</td><td>1.000</td><td>1933</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>590</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td><td></td><td>325</td><td>-0.23</td><td>-0.98</td><td>0.480</td><td>0.730</td><td>1.000</td><td>2309</td><td>tags=30%, list=21%, signal=36%</td></tr><tr><td class='lessen'>591</td><td>BURTON_ADIPOGENESIS_3</td><td></td><td>59</td><td>-0.41</td><td>-0.98</td><td>0.523</td><td>0.730</td><td>1.000</td><td>2414</td><td>tags=46%, list=22%, signal=58%</td></tr><tr><td class='lessen'>592</td><td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2</td><td></td><td>25</td><td>-0.27</td><td>-0.98</td><td>0.481</td><td>0.729</td><td>1.000</td><td>2470</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>593</td><td>KORKOLA_YOLK_SAC_TUMOR</td><td></td><td>35</td><td>-0.31</td><td>-0.98</td><td>0.476</td><td>0.730</td><td>1.000</td><td>2333</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>594</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>21</td><td>-0.41</td><td>-0.98</td><td>0.553</td><td>0.730</td><td>1.000</td><td>1815</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>595</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>46</td><td>-0.26</td><td>-0.98</td><td>0.451</td><td>0.730</td><td>1.000</td><td>730</td><td>tags=17%, list=7%, signal=19%</td></tr><tr><td class='lessen'>596</td><td>ELVIDGE_HYPOXIA_DN</td><td></td><td>79</td><td>-0.26</td><td>-0.98</td><td>0.444</td><td>0.730</td><td>1.000</td><td>1683</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>597</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP</td><td></td><td>26</td><td>-0.32</td><td>-0.98</td><td>0.471</td><td>0.729</td><td>1.000</td><td>733</td><td>tags=19%, list=7%, signal=21%</td></tr><tr><td class='lessen'>598</td><td>JIANG_AGING_HYPOTHALAMUS_DN</td><td></td><td>21</td><td>-0.31</td><td>-0.98</td><td>0.500</td><td>0.730</td><td>1.000</td><td>1100</td><td>tags=29%, list=10%, signal=32%</td></tr><tr><td class='lessen'>599</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE</td><td></td><td>46</td><td>-0.28</td><td>-0.97</td><td>0.480</td><td>0.733</td><td>1.000</td><td>656</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>600</td><td>LUI_TARGETS_OF_PAX8_PPARG_FUSION</td><td></td><td>15</td><td>-0.35</td><td>-0.97</td><td>0.526</td><td>0.732</td><td>1.000</td><td>1773</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>601</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN</td><td></td><td>65</td><td>-0.24</td><td>-0.97</td><td>0.532</td><td>0.731</td><td>1.000</td><td>2757</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>602</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>73</td><td>-0.24</td><td>-0.97</td><td>0.481</td><td>0.732</td><td>1.000</td><td>1930</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>603</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_DN</td><td></td><td>22</td><td>-0.29</td><td>-0.97</td><td>0.558</td><td>0.732</td><td>1.000</td><td>2426</td><td>tags=41%, list=22%, signal=53%</td></tr><tr><td class='lessen'>604</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td><td></td><td>76</td><td>-0.30</td><td>-0.97</td><td>0.425</td><td>0.731</td><td>1.000</td><td>2847</td><td>tags=41%, list=26%, signal=55%</td></tr><tr><td class='lessen'>605</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP</td><td></td><td>16</td><td>-0.32</td><td>-0.97</td><td>0.500</td><td>0.732</td><td>1.000</td><td>2313</td><td>tags=38%, list=21%, signal=48%</td></tr><tr><td class='lessen'>606</td><td>CHEBOTAEV_GR_TARGETS_DN</td><td></td><td>52</td><td>-0.24</td><td>-0.97</td><td>0.481</td><td>0.734</td><td>1.000</td><td>3018</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>607</td><td>SASAKI_ADULT_T_CELL_LEUKEMIA</td><td></td><td>94</td><td>-0.26</td><td>-0.97</td><td>0.510</td><td>0.737</td><td>1.000</td><td>2330</td><td>tags=37%, list=21%, signal=47%</td></tr><tr><td class='lessen'>608</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_UP</td><td></td><td>55</td><td>-0.24</td><td>-0.97</td><td>0.500</td><td>0.736</td><td>1.000</td><td>1203</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>609</td><td>LEE_NEURAL_CREST_STEM_CELL_UP</td><td></td><td>88</td><td>-0.22</td><td>-0.97</td><td>0.458</td><td>0.736</td><td>1.000</td><td>1852</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>610</td><td>ZUCCHI_METASTASIS_UP</td><td></td><td>17</td><td>-0.30</td><td>-0.97</td><td>0.463</td><td>0.735</td><td>1.000</td><td>669</td><td>tags=24%, list=6%, signal=25%</td></tr><tr><td class='lessen'>611</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>39</td><td>-0.26</td><td>-0.97</td><td>0.536</td><td>0.734</td><td>1.000</td><td>2732</td><td>tags=38%, list=25%, signal=51%</td></tr><tr><td class='lessen'>612</td><td>CHIBA_RESPONSE_TO_TSA_DN</td><td></td><td>16</td><td>-0.34</td><td>-0.97</td><td>0.422</td><td>0.733</td><td>1.000</td><td>3704</td><td>tags=63%, list=34%, signal=95%</td></tr><tr><td class='lessen'>613</td><td>CHESLER_BRAIN_HIGHEST_EXPRESSION</td><td></td><td>24</td><td>-0.29</td><td>-0.97</td><td>0.532</td><td>0.733</td><td>1.000</td><td>1491</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>614</td><td>MAEKAWA_ATF2_TARGETS</td><td></td><td>17</td><td>-0.35</td><td>-0.97</td><td>0.608</td><td>0.732</td><td>1.000</td><td>1613</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>615</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP</td><td></td><td>15</td><td>-0.37</td><td>-0.97</td><td>0.533</td><td>0.734</td><td>1.000</td><td>441</td><td>tags=13%, list=4%, signal=14%</td></tr><tr><td class='lessen'>616</td><td>YANAGIHARA_ESX1_TARGETS</td><td></td><td>19</td><td>-0.34</td><td>-0.96</td><td>0.442</td><td>0.734</td><td>1.000</td><td>405</td><td>tags=16%, list=4%, signal=16%</td></tr><tr><td class='lessen'>617</td><td>WOOD_EBV_EBNA1_TARGETS_UP</td><td></td><td>65</td><td>-0.24</td><td>-0.96</td><td>0.418</td><td>0.739</td><td>1.000</td><td>2117</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>618</td><td>PHONG_TNF_TARGETS_UP</td><td></td><td>36</td><td>-0.37</td><td>-0.96</td><td>0.462</td><td>0.739</td><td>1.000</td><td>2129</td><td>tags=36%, list=20%, signal=45%</td></tr><tr><td class='lessen'>619</td><td>NGUYEN_NOTCH1_TARGETS_DN</td><td></td><td>49</td><td>-0.24</td><td>-0.96</td><td>0.525</td><td>0.743</td><td>1.000</td><td>1139</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>620</td><td>RHODES_UNDIFFERENTIATED_CANCER</td><td></td><td>33</td><td>-0.42</td><td>-0.96</td><td>0.512</td><td>0.742</td><td>1.000</td><td>2156</td><td>tags=48%, list=20%, signal=60%</td></tr><tr><td class='lessen'>621</td><td>MOOTHA_VOXPHOS</td><td></td><td>49</td><td>-0.32</td><td>-0.96</td><td>0.525</td><td>0.742</td><td>1.000</td><td>3560</td><td>tags=51%, list=33%, signal=75%</td></tr><tr><td class='lessen'>622</td><td>KAYO_AGING_MUSCLE_DN</td><td></td><td>69</td><td>-0.24</td><td>-0.96</td><td>0.453</td><td>0.742</td><td>1.000</td><td>1933</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>623</td><td>RAO_BOUND_BY_SALL4_ISOFORM_A</td><td></td><td>80</td><td>-0.24</td><td>-0.96</td><td>0.490</td><td>0.741</td><td>1.000</td><td>3389</td><td>tags=40%, list=31%, signal=58%</td></tr><tr><td class='lessen'>624</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td><td></td><td>222</td><td>-0.24</td><td>-0.96</td><td>0.464</td><td>0.741</td><td>1.000</td><td>1736</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>625</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P6</td><td></td><td>52</td><td>-0.32</td><td>-0.96</td><td>0.476</td><td>0.745</td><td>1.000</td><td>2206</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>626</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>304</td><td>-0.21</td><td>-0.95</td><td>0.519</td><td>0.744</td><td>1.000</td><td>1626</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>627</td><td>VALK_AML_CLUSTER_1</td><td></td><td>18</td><td>-0.31</td><td>-0.95</td><td>0.492</td><td>0.743</td><td>1.000</td><td>796</td><td>tags=22%, list=7%, signal=24%</td></tr><tr><td class='lessen'>628</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td><td></td><td>143</td><td>-0.20</td><td>-0.95</td><td>0.460</td><td>0.743</td><td>1.000</td><td>2322</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>629</td><td>WENDT_COHESIN_TARGETS_UP</td><td></td><td>18</td><td>-0.31</td><td>-0.95</td><td>0.444</td><td>0.742</td><td>1.000</td><td>2942</td><td>tags=44%, list=27%, signal=61%</td></tr><tr><td class='lessen'>630</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP</td><td></td><td>61</td><td>-0.28</td><td>-0.95</td><td>0.451</td><td>0.743</td><td>1.000</td><td>1423</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>631</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>32</td><td>-0.28</td><td>-0.95</td><td>0.604</td><td>0.745</td><td>1.000</td><td>806</td><td>tags=19%, list=7%, signal=20%</td></tr><tr><td class='lessen'>632</td><td>VERHAAK_GLIOBLASTOMA_CLASSICAL</td><td></td><td>93</td><td>-0.24</td><td>-0.95</td><td>0.409</td><td>0.750</td><td>1.000</td><td>2804</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>633</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>29</td><td>-0.28</td><td>-0.95</td><td>0.540</td><td>0.751</td><td>1.000</td><td>1719</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>634</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>205</td><td>-0.20</td><td>-0.95</td><td>0.527</td><td>0.751</td><td>1.000</td><td>2574</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>635</td><td>WOOD_EBV_EBNA1_TARGETS_DN</td><td></td><td>27</td><td>-0.28</td><td>-0.95</td><td>0.545</td><td>0.751</td><td>1.000</td><td>2490</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>636</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_UP</td><td></td><td>19</td><td>-0.31</td><td>-0.95</td><td>0.536</td><td>0.751</td><td>1.000</td><td>2652</td><td>tags=47%, list=24%, signal=63%</td></tr><tr><td class='lessen'>637</td><td>FAELT_B_CLL_WITH_VH3_21_DN</td><td></td><td>31</td><td>-0.26</td><td>-0.95</td><td>0.558</td><td>0.752</td><td>1.000</td><td>2295</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>638</td><td>RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2</td><td></td><td>19</td><td>-0.34</td><td>-0.94</td><td>0.592</td><td>0.752</td><td>1.000</td><td>980</td><td>tags=26%, list=9%, signal=29%</td></tr><tr><td class='lessen'>639</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>250</td><td>-0.19</td><td>-0.94</td><td>0.647</td><td>0.756</td><td>1.000</td><td>2367</td><td>tags=28%, list=22%, signal=34%</td></tr><tr><td class='lessen'>640</td><td>PARK_HSC_AND_MULTIPOTENT_PROGENITORS</td><td></td><td>25</td><td>-0.29</td><td>-0.94</td><td>0.556</td><td>0.758</td><td>1.000</td><td>1817</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>641</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>123</td><td>-0.24</td><td>-0.94</td><td>0.561</td><td>0.760</td><td>1.000</td><td>2248</td><td>tags=31%, list=21%, signal=38%</td></tr><tr><td class='lessen'>642</td><td>GUILLAUMOND_KLF10_TARGETS_DN</td><td></td><td>16</td><td>-0.30</td><td>-0.94</td><td>0.483</td><td>0.759</td><td>1.000</td><td>887</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>643</td><td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td><td></td><td>61</td><td>-0.29</td><td>-0.94</td><td>0.596</td><td>0.760</td><td>1.000</td><td>1854</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>644</td><td>VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1</td><td></td><td>29</td><td>-0.31</td><td>-0.94</td><td>0.472</td><td>0.761</td><td>1.000</td><td>2133</td><td>tags=34%, list=20%, signal=43%</td></tr><tr><td class='lessen'>645</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP</td><td></td><td>17</td><td>-0.32</td><td>-0.94</td><td>0.447</td><td>0.763</td><td>1.000</td><td>2027</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>646</td><td>SCHLOSSER_SERUM_RESPONSE_UP</td><td></td><td>70</td><td>-0.26</td><td>-0.94</td><td>0.548</td><td>0.762</td><td>1.000</td><td>1904</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>647</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td><td></td><td>67</td><td>-0.27</td><td>-0.94</td><td>0.565</td><td>0.761</td><td>1.000</td><td>2221</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>648</td><td>MORI_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>44</td><td>-0.28</td><td>-0.93</td><td>0.417</td><td>0.761</td><td>1.000</td><td>2331</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>649</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>121</td><td>-0.30</td><td>-0.93</td><td>0.610</td><td>0.761</td><td>1.000</td><td>2713</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>650</td><td>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</td><td></td><td>166</td><td>-0.22</td><td>-0.93</td><td>0.542</td><td>0.760</td><td>1.000</td><td>1904</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>651</td><td>LOPES_METHYLATED_IN_COLON_CANCER_UP</td><td></td><td>19</td><td>-0.34</td><td>-0.93</td><td>0.638</td><td>0.761</td><td>1.000</td><td>2816</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>652</td><td>BYSTROEM_CORRELATED_WITH_IL5_DN</td><td></td><td>38</td><td>-0.29</td><td>-0.93</td><td>0.585</td><td>0.761</td><td>1.000</td><td>2382</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>653</td><td>SHIPP_DLBCL_CURED_VS_FATAL_DN</td><td></td><td>26</td><td>-0.26</td><td>-0.93</td><td>0.667</td><td>0.761</td><td>1.000</td><td>2784</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>654</td><td>KYNG_DNA_DAMAGE_BY_4NQO_OR_UV</td><td></td><td>40</td><td>-0.25</td><td>-0.93</td><td>0.650</td><td>0.761</td><td>1.000</td><td>2131</td><td>tags=33%, list=20%, signal=40%</td></tr><tr><td class='lessen'>655</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>52</td><td>-0.27</td><td>-0.93</td><td>0.542</td><td>0.763</td><td>1.000</td><td>2108</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>656</td><td>STEIN_ESRRA_TARGETS</td><td></td><td>278</td><td>-0.22</td><td>-0.93</td><td>0.561</td><td>0.763</td><td>1.000</td><td>2347</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>657</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>21</td><td>-0.32</td><td>-0.93</td><td>0.553</td><td>0.762</td><td>1.000</td><td>1525</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>658</td><td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td><td></td><td>49</td><td>-0.25</td><td>-0.93</td><td>0.571</td><td>0.761</td><td>1.000</td><td>1574</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>659</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>171</td><td>-0.20</td><td>-0.93</td><td>0.583</td><td>0.760</td><td>1.000</td><td>2257</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>660</td><td>LU_TUMOR_ANGIOGENESIS_UP</td><td></td><td>15</td><td>-0.32</td><td>-0.93</td><td>0.563</td><td>0.761</td><td>1.000</td><td>1597</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>661</td><td>GENTILE_UV_RESPONSE_CLUSTER_D6</td><td></td><td>21</td><td>-0.32</td><td>-0.93</td><td>0.491</td><td>0.762</td><td>1.000</td><td>2912</td><td>tags=52%, list=27%, signal=71%</td></tr><tr><td class='lessen'>662</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP</td><td></td><td>97</td><td>-0.21</td><td>-0.93</td><td>0.591</td><td>0.761</td><td>1.000</td><td>1263</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>663</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP</td><td></td><td>16</td><td>-0.30</td><td>-0.93</td><td>0.667</td><td>0.760</td><td>1.000</td><td>1156</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>664</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>38</td><td>-0.28</td><td>-0.93</td><td>0.609</td><td>0.759</td><td>1.000</td><td>2097</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>665</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN</td><td></td><td>50</td><td>-0.30</td><td>-0.92</td><td>0.509</td><td>0.764</td><td>1.000</td><td>2712</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>666</td><td>XU_GH1_AUTOCRINE_TARGETS_UP</td><td></td><td>132</td><td>-0.20</td><td>-0.92</td><td>0.543</td><td>0.764</td><td>1.000</td><td>1920</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>667</td><td>GRADE_COLON_VS_RECTAL_CANCER_UP</td><td></td><td>26</td><td>-0.25</td><td>-0.92</td><td>0.580</td><td>0.769</td><td>1.000</td><td>1043</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>668</td><td>CORRE_MULTIPLE_MYELOMA_DN</td><td></td><td>33</td><td>-0.26</td><td>-0.92</td><td>0.633</td><td>0.769</td><td>1.000</td><td>3377</td><td>tags=45%, list=31%, signal=66%</td></tr><tr><td class='lessen'>669</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>100</td><td>-0.26</td><td>-0.92</td><td>0.500</td><td>0.768</td><td>1.000</td><td>2337</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>670</td><td>WESTON_VEGFA_TARGETS_3HR</td><td></td><td>45</td><td>-0.25</td><td>-0.92</td><td>0.651</td><td>0.768</td><td>1.000</td><td>2160</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>671</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>38</td><td>-0.28</td><td>-0.92</td><td>0.568</td><td>0.774</td><td>1.000</td><td>2973</td><td>tags=42%, list=27%, signal=58%</td></tr><tr><td class='lessen'>672</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</td><td></td><td>41</td><td>-0.26</td><td>-0.92</td><td>0.585</td><td>0.774</td><td>1.000</td><td>3145</td><td>tags=39%, list=29%, signal=55%</td></tr><tr><td class='lessen'>673</td><td>CHANG_IMMORTALIZED_BY_HPV31_UP</td><td></td><td>40</td><td>-0.26</td><td>-0.92</td><td>0.571</td><td>0.775</td><td>1.000</td><td>1953</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>674</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td><td></td><td>20</td><td>-0.38</td><td>-0.92</td><td>0.561</td><td>0.774</td><td>1.000</td><td>3786</td><td>tags=50%, list=35%, signal=77%</td></tr><tr><td class='lessen'>675</td><td>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</td><td></td><td>30</td><td>-0.26</td><td>-0.92</td><td>0.580</td><td>0.773</td><td>1.000</td><td>2648</td><td>tags=37%, list=24%, signal=48%</td></tr><tr><td class='lessen'>676</td><td>WONG_IFNA2_RESISTANCE_DN</td><td></td><td>16</td><td>-0.29</td><td>-0.92</td><td>0.608</td><td>0.772</td><td>1.000</td><td>2200</td><td>tags=44%, list=20%, signal=55%</td></tr><tr><td class='lessen'>677</td><td>DORN_ADENOVIRUS_INFECTION_32HR_DN</td><td></td><td>16</td><td>-0.37</td><td>-0.91</td><td>0.612</td><td>0.771</td><td>1.000</td><td>2134</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>678</td><td>YAGI_AML_WITH_INV_16_TRANSLOCATION</td><td></td><td>242</td><td>-0.18</td><td>-0.91</td><td>0.720</td><td>0.770</td><td>1.000</td><td>2811</td><td>tags=32%, list=26%, signal=42%</td></tr><tr><td class='lessen'>679</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_UP</td><td></td><td>37</td><td>-0.27</td><td>-0.91</td><td>0.508</td><td>0.770</td><td>1.000</td><td>1127</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>680</td><td>AUNG_GASTRIC_CANCER</td><td></td><td>25</td><td>-0.27</td><td>-0.91</td><td>0.685</td><td>0.770</td><td>1.000</td><td>3287</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>681</td><td>MULLIGHAN_MLL_SIGNATURE_2_DN</td><td></td><td>160</td><td>-0.20</td><td>-0.91</td><td>0.638</td><td>0.774</td><td>1.000</td><td>2046</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>682</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td><td></td><td>98</td><td>-0.25</td><td>-0.91</td><td>0.582</td><td>0.774</td><td>1.000</td><td>2323</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>683</td><td>GERHOLD_ADIPOGENESIS_DN</td><td></td><td>42</td><td>-0.28</td><td>-0.91</td><td>0.583</td><td>0.775</td><td>1.000</td><td>2133</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>684</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2</td><td></td><td>82</td><td>-0.21</td><td>-0.91</td><td>0.574</td><td>0.779</td><td>1.000</td><td>2433</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>685</td><td>ONDER_CDH1_TARGETS_1_DN</td><td></td><td>94</td><td>-0.24</td><td>-0.91</td><td>0.583</td><td>0.781</td><td>1.000</td><td>2959</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>686</td><td>SANSOM_APC_TARGETS_REQUIRE_MYC</td><td></td><td>103</td><td>-0.26</td><td>-0.91</td><td>0.617</td><td>0.781</td><td>1.000</td><td>947</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>687</td><td>BROWNE_HCMV_INFECTION_14HR_UP</td><td></td><td>78</td><td>-0.23</td><td>-0.91</td><td>0.589</td><td>0.780</td><td>1.000</td><td>1613</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>688</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN</td><td></td><td>28</td><td>-0.27</td><td>-0.90</td><td>0.581</td><td>0.787</td><td>1.000</td><td>1826</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>689</td><td>ELLWOOD_MYC_TARGETS_DN</td><td></td><td>18</td><td>-0.32</td><td>-0.90</td><td>0.603</td><td>0.787</td><td>1.000</td><td>1646</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>690</td><td>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</td><td></td><td>23</td><td>-0.29</td><td>-0.90</td><td>0.509</td><td>0.787</td><td>1.000</td><td>1251</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>691</td><td>MULLIGHAN_NPM1_SIGNATURE_3_DN</td><td></td><td>83</td><td>-0.21</td><td>-0.90</td><td>0.660</td><td>0.791</td><td>1.000</td><td>2709</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>692</td><td>MARKEY_RB1_CHRONIC_LOF_UP</td><td></td><td>64</td><td>-0.24</td><td>-0.90</td><td>0.596</td><td>0.790</td><td>1.000</td><td>1188</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>693</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td><td></td><td>80</td><td>-0.23</td><td>-0.90</td><td>0.620</td><td>0.790</td><td>1.000</td><td>1451</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>694</td><td>YE_METASTATIC_LIVER_CANCER</td><td></td><td>16</td><td>-0.33</td><td>-0.90</td><td>0.633</td><td>0.789</td><td>1.000</td><td>2871</td><td>tags=50%, list=26%, signal=68%</td></tr><tr><td class='lessen'>695</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td><td></td><td>138</td><td>-0.19</td><td>-0.90</td><td>0.698</td><td>0.790</td><td>1.000</td><td>2595</td><td>tags=28%, list=24%, signal=37%</td></tr><tr><td class='lessen'>696</td><td>GYORFFY_MITOXANTRONE_RESISTANCE</td><td></td><td>34</td><td>-0.26</td><td>-0.90</td><td>0.694</td><td>0.792</td><td>1.000</td><td>1372</td><td>tags=21%, list=13%, signal=23%</td></tr><tr><td class='lessen'>697</td><td>ONKEN_UVEAL_MELANOMA_DN</td><td></td><td>279</td><td>-0.21</td><td>-0.89</td><td>0.678</td><td>0.794</td><td>1.000</td><td>2314</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>698</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HEMGN</td><td></td><td>22</td><td>-0.30</td><td>-0.89</td><td>0.633</td><td>0.798</td><td>1.000</td><td>2916</td><td>tags=50%, list=27%, signal=68%</td></tr><tr><td class='lessen'>699</td><td>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</td><td></td><td>38</td><td>-0.23</td><td>-0.89</td><td>0.615</td><td>0.798</td><td>1.000</td><td>2625</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>700</td><td>KATSANOU_ELAVL1_TARGETS_DN</td><td></td><td>71</td><td>-0.23</td><td>-0.89</td><td>0.646</td><td>0.798</td><td>1.000</td><td>2450</td><td>tags=32%, list=23%, signal=42%</td></tr><tr><td class='lessen'>701</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>202</td><td>-0.21</td><td>-0.89</td><td>0.569</td><td>0.798</td><td>1.000</td><td>2370</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>702</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>90</td><td>-0.29</td><td>-0.89</td><td>0.481</td><td>0.797</td><td>1.000</td><td>2161</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>703</td><td>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</td><td></td><td>143</td><td>-0.20</td><td>-0.89</td><td>0.625</td><td>0.799</td><td>1.000</td><td>2007</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>704</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</td><td></td><td>20</td><td>-0.28</td><td>-0.89</td><td>0.618</td><td>0.798</td><td>1.000</td><td>1113</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>705</td><td>GU_PDEF_TARGETS_UP</td><td></td><td>38</td><td>-0.24</td><td>-0.89</td><td>0.649</td><td>0.797</td><td>1.000</td><td>1615</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>706</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP</td><td></td><td>25</td><td>-0.29</td><td>-0.89</td><td>0.654</td><td>0.798</td><td>1.000</td><td>2615</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>707</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>137</td><td>-0.25</td><td>-0.89</td><td>0.587</td><td>0.797</td><td>1.000</td><td>1976</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>708</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</td><td></td><td>22</td><td>-0.27</td><td>-0.89</td><td>0.615</td><td>0.797</td><td>1.000</td><td>1672</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>709</td><td>WANG_MLL_TARGETS</td><td></td><td>143</td><td>-0.19</td><td>-0.89</td><td>0.795</td><td>0.797</td><td>1.000</td><td>1718</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>710</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11</td><td></td><td>49</td><td>-0.25</td><td>-0.88</td><td>0.586</td><td>0.803</td><td>1.000</td><td>1218</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>711</td><td>SANSOM_APC_MYC_TARGETS</td><td></td><td>110</td><td>-0.22</td><td>-0.88</td><td>0.681</td><td>0.802</td><td>1.000</td><td>2425</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>712</td><td>CROMER_TUMORIGENESIS_DN</td><td></td><td>23</td><td>-0.28</td><td>-0.88</td><td>0.714</td><td>0.801</td><td>1.000</td><td>1250</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>713</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP</td><td></td><td>25</td><td>-0.26</td><td>-0.88</td><td>0.632</td><td>0.805</td><td>1.000</td><td>928</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>714</td><td>BOYLAN_MULTIPLE_MYELOMA_C_DN</td><td></td><td>35</td><td>-0.26</td><td>-0.88</td><td>0.647</td><td>0.807</td><td>1.000</td><td>1644</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>715</td><td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td><td></td><td>16</td><td>-0.30</td><td>-0.88</td><td>0.667</td><td>0.807</td><td>1.000</td><td>2804</td><td>tags=38%, list=26%, signal=50%</td></tr><tr><td class='lessen'>716</td><td>ROESSLER_LIVER_CANCER_METASTASIS_DN</td><td></td><td>21</td><td>-0.28</td><td>-0.88</td><td>0.577</td><td>0.808</td><td>1.000</td><td>2970</td><td>tags=43%, list=27%, signal=59%</td></tr><tr><td class='lessen'>717</td><td>BROWNE_HCMV_INFECTION_20HR_UP</td><td></td><td>132</td><td>-0.21</td><td>-0.88</td><td>0.727</td><td>0.809</td><td>1.000</td><td>2043</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>718</td><td>DOANE_BREAST_CANCER_ESR1_DN</td><td></td><td>27</td><td>-0.28</td><td>-0.88</td><td>0.642</td><td>0.808</td><td>1.000</td><td>928</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>719</td><td>BOCHKIS_FOXA2_TARGETS</td><td></td><td>222</td><td>-0.18</td><td>-0.88</td><td>0.759</td><td>0.807</td><td>1.000</td><td>1759</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>720</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td><td></td><td>78</td><td>-0.24</td><td>-0.87</td><td>0.519</td><td>0.808</td><td>1.000</td><td>2076</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>721</td><td>GROSS_HYPOXIA_VIA_HIF1A_UP</td><td></td><td>38</td><td>-0.27</td><td>-0.87</td><td>0.582</td><td>0.808</td><td>1.000</td><td>2611</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>722</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>49</td><td>-0.22</td><td>-0.87</td><td>0.724</td><td>0.809</td><td>1.000</td><td>1644</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>723</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td><td></td><td>139</td><td>-0.20</td><td>-0.87</td><td>0.633</td><td>0.811</td><td>1.000</td><td>1953</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>724</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_7_UP</td><td></td><td>60</td><td>-0.21</td><td>-0.87</td><td>0.737</td><td>0.811</td><td>1.000</td><td>1171</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>725</td><td>LEE_AGING_MUSCLE_UP</td><td></td><td>25</td><td>-0.28</td><td>-0.87</td><td>0.633</td><td>0.811</td><td>1.000</td><td>669</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>726</td><td>DORSAM_HOXA9_TARGETS_UP</td><td></td><td>17</td><td>-0.33</td><td>-0.87</td><td>0.622</td><td>0.811</td><td>1.000</td><td>3852</td><td>tags=59%, list=35%, signal=91%</td></tr><tr><td class='lessen'>727</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>173</td><td>-0.23</td><td>-0.87</td><td>0.511</td><td>0.810</td><td>1.000</td><td>2005</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>728</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td><td></td><td>18</td><td>-0.28</td><td>-0.87</td><td>0.592</td><td>0.814</td><td>1.000</td><td>537</td><td>tags=17%, list=5%, signal=18%</td></tr><tr><td class='lessen'>729</td><td>LI_LUNG_CANCER</td><td></td><td>21</td><td>-0.26</td><td>-0.87</td><td>0.588</td><td>0.813</td><td>1.000</td><td>1597</td><td>tags=29%, list=15%, signal=33%</td></tr><tr><td class='lessen'>730</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_UP</td><td></td><td>128</td><td>-0.21</td><td>-0.87</td><td>0.720</td><td>0.814</td><td>1.000</td><td>1904</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>731</td><td>VANTVEER_BREAST_CANCER_ESR1_UP</td><td></td><td>74</td><td>-0.23</td><td>-0.86</td><td>0.700</td><td>0.814</td><td>1.000</td><td>2162</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>732</td><td>WIERENGA_STAT5A_TARGETS_GROUP2</td><td></td><td>30</td><td>-0.29</td><td>-0.86</td><td>0.600</td><td>0.814</td><td>1.000</td><td>164</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>733</td><td>CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN</td><td></td><td>23</td><td>-0.26</td><td>-0.86</td><td>0.635</td><td>0.813</td><td>1.000</td><td>1125</td><td>tags=26%, list=10%, signal=29%</td></tr><tr><td class='lessen'>734</td><td>BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>22</td><td>-0.35</td><td>-0.86</td><td>0.534</td><td>0.812</td><td>1.000</td><td>2720</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>735</td><td>HU_ANGIOGENESIS_DN</td><td></td><td>18</td><td>-0.29</td><td>-0.86</td><td>0.583</td><td>0.812</td><td>1.000</td><td>2673</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>736</td><td>SMID_BREAST_CANCER_LUMINAL_B_UP</td><td></td><td>95</td><td>-0.22</td><td>-0.86</td><td>0.729</td><td>0.812</td><td>1.000</td><td>2005</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>737</td><td>WAGNER_APO2_SENSITIVITY</td><td></td><td>15</td><td>-0.30</td><td>-0.86</td><td>0.620</td><td>0.815</td><td>1.000</td><td>233</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>738</td><td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</td><td></td><td>35</td><td>-0.25</td><td>-0.86</td><td>0.688</td><td>0.816</td><td>1.000</td><td>3189</td><td>tags=49%, list=29%, signal=68%</td></tr><tr><td class='lessen'>739</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td><td></td><td>26</td><td>-0.29</td><td>-0.86</td><td>0.596</td><td>0.815</td><td>1.000</td><td>3460</td><td>tags=54%, list=32%, signal=79%</td></tr><tr><td class='lessen'>740</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>116</td><td>-0.20</td><td>-0.86</td><td>0.795</td><td>0.819</td><td>1.000</td><td>2870</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>741</td><td>ZAMORA_NOS2_TARGETS_DN</td><td></td><td>43</td><td>-0.24</td><td>-0.86</td><td>0.760</td><td>0.821</td><td>1.000</td><td>2147</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>742</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>222</td><td>-0.27</td><td>-0.85</td><td>0.609</td><td>0.822</td><td>1.000</td><td>2036</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>743</td><td>WANG_BARRETTS_ESOPHAGUS_DN</td><td></td><td>15</td><td>-0.30</td><td>-0.85</td><td>0.583</td><td>0.822</td><td>1.000</td><td>930</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>744</td><td>JAEGER_METASTASIS_DN</td><td></td><td>140</td><td>-0.23</td><td>-0.85</td><td>0.549</td><td>0.821</td><td>1.000</td><td>1692</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>745</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP</td><td></td><td>17</td><td>-0.28</td><td>-0.85</td><td>0.745</td><td>0.821</td><td>1.000</td><td>3441</td><td>tags=47%, list=32%, signal=69%</td></tr><tr><td class='lessen'>746</td><td>BORLAK_LIVER_CANCER_EGF_UP</td><td></td><td>31</td><td>-0.28</td><td>-0.85</td><td>0.649</td><td>0.821</td><td>1.000</td><td>1960</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>747</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td><td></td><td>378</td><td>-0.20</td><td>-0.85</td><td>0.667</td><td>0.823</td><td>1.000</td><td>1643</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>748</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP</td><td></td><td>24</td><td>-0.29</td><td>-0.85</td><td>0.750</td><td>0.822</td><td>1.000</td><td>1229</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>749</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>54</td><td>-0.24</td><td>-0.85</td><td>0.630</td><td>0.821</td><td>1.000</td><td>2145</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>750</td><td>ROESSLER_LIVER_CANCER_METASTASIS_UP</td><td></td><td>64</td><td>-0.21</td><td>-0.85</td><td>0.771</td><td>0.824</td><td>1.000</td><td>2630</td><td>tags=34%, list=24%, signal=45%</td></tr><tr><td class='lessen'>751</td><td>KRIEG_HYPOXIA_VIA_KDM3A</td><td></td><td>33</td><td>-0.31</td><td>-0.85</td><td>0.600</td><td>0.823</td><td>1.000</td><td>2156</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>752</td><td>WANG_SMARCE1_TARGETS_DN</td><td></td><td>198</td><td>-0.20</td><td>-0.85</td><td>0.692</td><td>0.823</td><td>1.000</td><td>1746</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>753</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP</td><td></td><td>37</td><td>-0.24</td><td>-0.85</td><td>0.717</td><td>0.823</td><td>1.000</td><td>1379</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>754</td><td>JI_RESPONSE_TO_FSH_DN</td><td></td><td>35</td><td>-0.26</td><td>-0.85</td><td>0.638</td><td>0.822</td><td>1.000</td><td>3398</td><td>tags=49%, list=31%, signal=70%</td></tr><tr><td class='lessen'>755</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>230</td><td>-0.23</td><td>-0.85</td><td>0.681</td><td>0.822</td><td>1.000</td><td>2516</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>756</td><td>AMUNDSON_GENOTOXIC_SIGNATURE</td><td></td><td>61</td><td>-0.22</td><td>-0.85</td><td>0.755</td><td>0.824</td><td>1.000</td><td>2793</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>757</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP</td><td></td><td>19</td><td>-0.32</td><td>-0.84</td><td>0.646</td><td>0.833</td><td>1.000</td><td>2804</td><td>tags=47%, list=26%, signal=64%</td></tr><tr><td class='lessen'>758</td><td>ENGELMANN_CANCER_PROGENITORS_DN</td><td></td><td>37</td><td>-0.25</td><td>-0.84</td><td>0.711</td><td>0.834</td><td>1.000</td><td>939</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>759</td><td>MCCLUNG_DELTA_FOSB_TARGETS_8WK</td><td></td><td>28</td><td>-0.24</td><td>-0.84</td><td>0.717</td><td>0.833</td><td>1.000</td><td>1626</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>760</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>113</td><td>-0.25</td><td>-0.84</td><td>0.600</td><td>0.833</td><td>1.000</td><td>3287</td><td>tags=45%, list=30%, signal=64%</td></tr><tr><td class='lessen'>761</td><td>HOWLIN_PUBERTAL_MAMMARY_GLAND</td><td></td><td>39</td><td>-0.24</td><td>-0.84</td><td>0.707</td><td>0.836</td><td>1.000</td><td>1362</td><td>tags=21%, list=13%, signal=23%</td></tr><tr><td class='lessen'>762</td><td>DELACROIX_RAR_TARGETS_UP</td><td></td><td>25</td><td>-0.27</td><td>-0.84</td><td>0.574</td><td>0.835</td><td>1.000</td><td>1239</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>763</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_DN</td><td></td><td>82</td><td>-0.20</td><td>-0.84</td><td>0.760</td><td>0.834</td><td>1.000</td><td>1611</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>764</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</td><td></td><td>60</td><td>-0.22</td><td>-0.83</td><td>0.694</td><td>0.838</td><td>1.000</td><td>1646</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>765</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td><td></td><td>33</td><td>-0.24</td><td>-0.83</td><td>0.661</td><td>0.839</td><td>1.000</td><td>2355</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>766</td><td>STEIN_ESRRA_TARGETS_DN</td><td></td><td>56</td><td>-0.22</td><td>-0.83</td><td>0.741</td><td>0.839</td><td>1.000</td><td>1826</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>767</td><td>NADLER_OBESITY_DN</td><td></td><td>25</td><td>-0.26</td><td>-0.83</td><td>0.650</td><td>0.838</td><td>1.000</td><td>262</td><td>tags=12%, list=2%, signal=12%</td></tr><tr><td class='lessen'>768</td><td>SUNG_METASTASIS_STROMA_DN</td><td></td><td>27</td><td>-0.26</td><td>-0.83</td><td>0.609</td><td>0.838</td><td>1.000</td><td>3120</td><td>tags=41%, list=29%, signal=57%</td></tr><tr><td class='lessen'>769</td><td>MELLMAN_TUT1_TARGETS_DN</td><td></td><td>25</td><td>-0.24</td><td>-0.83</td><td>0.815</td><td>0.837</td><td>1.000</td><td>273</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>770</td><td>RAMASWAMY_METASTASIS_DN</td><td></td><td>35</td><td>-0.26</td><td>-0.83</td><td>0.667</td><td>0.836</td><td>1.000</td><td>2608</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>771</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP</td><td></td><td>15</td><td>-0.30</td><td>-0.83</td><td>0.625</td><td>0.837</td><td>1.000</td><td>2876</td><td>tags=33%, list=26%, signal=45%</td></tr><tr><td class='lessen'>772</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>48</td><td>-0.27</td><td>-0.83</td><td>0.689</td><td>0.840</td><td>1.000</td><td>2281</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>773</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN</td><td></td><td>84</td><td>-0.23</td><td>-0.83</td><td>0.733</td><td>0.842</td><td>1.000</td><td>3260</td><td>tags=39%, list=30%, signal=56%</td></tr><tr><td class='lessen'>774</td><td>BARIS_THYROID_CANCER_DN</td><td></td><td>43</td><td>-0.22</td><td>-0.82</td><td>0.724</td><td>0.842</td><td>1.000</td><td>2958</td><td>tags=37%, list=27%, signal=51%</td></tr><tr><td class='lessen'>775</td><td>PEART_HDAC_PROLIFERATION_CLUSTER_DN</td><td></td><td>38</td><td>-0.24</td><td>-0.82</td><td>0.773</td><td>0.841</td><td>1.000</td><td>1239</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>776</td><td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN</td><td></td><td>48</td><td>-0.23</td><td>-0.82</td><td>0.673</td><td>0.841</td><td>1.000</td><td>1615</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>777</td><td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td><td></td><td>29</td><td>-0.24</td><td>-0.82</td><td>0.773</td><td>0.841</td><td>1.000</td><td>1985</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>778</td><td>MCCLUNG_CREB1_TARGETS_UP</td><td></td><td>58</td><td>-0.22</td><td>-0.82</td><td>0.725</td><td>0.842</td><td>1.000</td><td>2519</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>779</td><td>WANG_LMO4_TARGETS_UP</td><td></td><td>198</td><td>-0.18</td><td>-0.82</td><td>0.745</td><td>0.845</td><td>1.000</td><td>2200</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>780</td><td>BERNARD_PPAPDC1B_TARGETS_DN</td><td></td><td>33</td><td>-0.24</td><td>-0.82</td><td>0.768</td><td>0.844</td><td>1.000</td><td>2393</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>781</td><td>BROWNE_HCMV_INFECTION_8HR_DN</td><td></td><td>27</td><td>-0.22</td><td>-0.82</td><td>0.870</td><td>0.844</td><td>1.000</td><td>2213</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>782</td><td>SCIBETTA_KDM5B_TARGETS_DN</td><td></td><td>46</td><td>-0.28</td><td>-0.82</td><td>0.653</td><td>0.846</td><td>1.000</td><td>2161</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>783</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D</td><td></td><td>147</td><td>-0.19</td><td>-0.82</td><td>0.880</td><td>0.846</td><td>1.000</td><td>2345</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>784</td><td>JEPSEN_SMRT_TARGETS</td><td></td><td>18</td><td>-0.25</td><td>-0.81</td><td>0.783</td><td>0.850</td><td>1.000</td><td>1764</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>785</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN</td><td></td><td>43</td><td>-0.23</td><td>-0.81</td><td>0.809</td><td>0.850</td><td>1.000</td><td>1887</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>786</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>28</td><td>-0.27</td><td>-0.81</td><td>0.614</td><td>0.849</td><td>1.000</td><td>2598</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>787</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td><td></td><td>94</td><td>-0.19</td><td>-0.81</td><td>0.750</td><td>0.849</td><td>1.000</td><td>1613</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>788</td><td>MOOTHA_MITOCHONDRIA</td><td></td><td>256</td><td>-0.21</td><td>-0.81</td><td>0.649</td><td>0.849</td><td>1.000</td><td>1344</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>789</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>38</td><td>-0.25</td><td>-0.81</td><td>0.654</td><td>0.849</td><td>1.000</td><td>2754</td><td>tags=47%, list=25%, signal=63%</td></tr><tr><td class='lessen'>790</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_4</td><td></td><td>29</td><td>-0.25</td><td>-0.81</td><td>0.667</td><td>0.849</td><td>1.000</td><td>161</td><td>tags=10%, list=1%, signal=10%</td></tr><tr><td class='lessen'>791</td><td>MOOTHA_PGC</td><td></td><td>219</td><td>-0.18</td><td>-0.81</td><td>0.690</td><td>0.848</td><td>1.000</td><td>2429</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>792</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</td><td></td><td>17</td><td>-0.27</td><td>-0.81</td><td>0.700</td><td>0.848</td><td>1.000</td><td>1936</td><td>tags=35%, list=18%, signal=43%</td></tr><tr><td class='lessen'>793</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP</td><td></td><td>21</td><td>-0.25</td><td>-0.81</td><td>0.714</td><td>0.848</td><td>1.000</td><td>1586</td><td>tags=29%, list=15%, signal=33%</td></tr><tr><td class='lessen'>794</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN</td><td></td><td>51</td><td>-0.24</td><td>-0.81</td><td>0.767</td><td>0.848</td><td>1.000</td><td>1409</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>795</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP</td><td></td><td>77</td><td>-0.22</td><td>-0.81</td><td>0.755</td><td>0.848</td><td>1.000</td><td>2160</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>796</td><td>STEIN_ESRRA_TARGETS_UP</td><td></td><td>196</td><td>-0.20</td><td>-0.81</td><td>0.655</td><td>0.847</td><td>1.000</td><td>2333</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>797</td><td>MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>16</td><td>-0.25</td><td>-0.81</td><td>0.750</td><td>0.851</td><td>1.000</td><td>3237</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>798</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN</td><td></td><td>75</td><td>-0.20</td><td>-0.80</td><td>0.741</td><td>0.851</td><td>1.000</td><td>1785</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>799</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP</td><td></td><td>129</td><td>-0.19</td><td>-0.80</td><td>0.870</td><td>0.851</td><td>1.000</td><td>2327</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>800</td><td>SCHRAMM_INHBA_TARGETS_DN</td><td></td><td>19</td><td>-0.26</td><td>-0.80</td><td>0.729</td><td>0.855</td><td>1.000</td><td>1793</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>801</td><td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>23</td><td>-0.25</td><td>-0.80</td><td>0.724</td><td>0.856</td><td>1.000</td><td>807</td><td>tags=17%, list=7%, signal=19%</td></tr><tr><td class='lessen'>802</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td><td></td><td>115</td><td>-0.19</td><td>-0.80</td><td>0.807</td><td>0.855</td><td>1.000</td><td>2286</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>803</td><td>IGARASHI_ATF4_TARGETS_DN</td><td></td><td>47</td><td>-0.21</td><td>-0.80</td><td>0.885</td><td>0.854</td><td>1.000</td><td>2567</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>804</td><td>RICKMAN_HEAD_AND_NECK_CANCER_E</td><td></td><td>42</td><td>-0.25</td><td>-0.80</td><td>0.771</td><td>0.854</td><td>1.000</td><td>1352</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>805</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P7</td><td></td><td>47</td><td>-0.22</td><td>-0.80</td><td>0.822</td><td>0.854</td><td>1.000</td><td>2957</td><td>tags=34%, list=27%, signal=47%</td></tr><tr><td class='lessen'>806</td><td>MCCLUNG_COCAIN_REWARD_4WK</td><td></td><td>44</td><td>-0.21</td><td>-0.80</td><td>0.863</td><td>0.855</td><td>1.000</td><td>2241</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>807</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>28</td><td>-0.22</td><td>-0.80</td><td>0.773</td><td>0.855</td><td>1.000</td><td>1230</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>808</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>50</td><td>-0.26</td><td>-0.80</td><td>0.791</td><td>0.855</td><td>1.000</td><td>2731</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>809</td><td>MATZUK_SPERMATOCYTE</td><td></td><td>49</td><td>-0.21</td><td>-0.79</td><td>0.844</td><td>0.859</td><td>1.000</td><td>2620</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>810</td><td>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN</td><td></td><td>16</td><td>-0.28</td><td>-0.79</td><td>0.745</td><td>0.862</td><td>1.000</td><td>2248</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>811</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP</td><td></td><td>22</td><td>-0.24</td><td>-0.79</td><td>0.769</td><td>0.861</td><td>1.000</td><td>3683</td><td>tags=45%, list=34%, signal=69%</td></tr><tr><td class='lessen'>812</td><td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td><td></td><td>28</td><td>-0.24</td><td>-0.79</td><td>0.852</td><td>0.862</td><td>1.000</td><td>3782</td><td>tags=50%, list=35%, signal=76%</td></tr><tr><td class='lessen'>813</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>43</td><td>-0.23</td><td>-0.79</td><td>0.889</td><td>0.865</td><td>1.000</td><td>2016</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>814</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_2_UP</td><td></td><td>19</td><td>-0.30</td><td>-0.79</td><td>0.745</td><td>0.864</td><td>1.000</td><td>838</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>815</td><td>DUAN_PRDM5_TARGETS</td><td></td><td>41</td><td>-0.23</td><td>-0.79</td><td>0.771</td><td>0.864</td><td>1.000</td><td>2724</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>816</td><td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td><td></td><td>249</td><td>-0.18</td><td>-0.78</td><td>0.915</td><td>0.865</td><td>1.000</td><td>2359</td><td>tags=25%, list=22%, signal=31%</td></tr><tr><td class='lessen'>817</td><td>POS_HISTAMINE_RESPONSE_NETWORK</td><td></td><td>16</td><td>-0.27</td><td>-0.78</td><td>0.780</td><td>0.864</td><td>1.000</td><td>1186</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>818</td><td>DELASERNA_MYOD_TARGETS_DN</td><td></td><td>30</td><td>-0.22</td><td>-0.78</td><td>0.837</td><td>0.864</td><td>1.000</td><td>1397</td><td>tags=23%, list=13%, signal=27%</td></tr><tr><td class='lessen'>819</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</td><td></td><td>38</td><td>-0.21</td><td>-0.78</td><td>0.852</td><td>0.864</td><td>1.000</td><td>2881</td><td>tags=39%, list=26%, signal=53%</td></tr><tr><td class='lessen'>820</td><td>LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE</td><td></td><td>22</td><td>-0.24</td><td>-0.78</td><td>0.750</td><td>0.863</td><td>1.000</td><td>2160</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>821</td><td>XU_GH1_EXOGENOUS_TARGETS_UP</td><td></td><td>48</td><td>-0.23</td><td>-0.78</td><td>0.792</td><td>0.864</td><td>1.000</td><td>2049</td><td>tags=17%, list=19%, signal=20%</td></tr><tr><td class='lessen'>822</td><td>LABBE_WNT3A_TARGETS_UP</td><td></td><td>66</td><td>-0.22</td><td>-0.78</td><td>0.825</td><td>0.864</td><td>1.000</td><td>2117</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>823</td><td>SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC</td><td></td><td>58</td><td>-0.23</td><td>-0.78</td><td>0.760</td><td>0.867</td><td>1.000</td><td>2915</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>824</td><td>PECE_MAMMARY_STEM_CELL_UP</td><td></td><td>69</td><td>-0.21</td><td>-0.77</td><td>0.746</td><td>0.873</td><td>1.000</td><td>2627</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>825</td><td>CHENG_IMPRINTED_BY_ESTRADIOL</td><td></td><td>47</td><td>-0.21</td><td>-0.77</td><td>0.782</td><td>0.873</td><td>1.000</td><td>2081</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>826</td><td>SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN</td><td></td><td>19</td><td>-0.25</td><td>-0.77</td><td>0.845</td><td>0.876</td><td>1.000</td><td>3332</td><td>tags=42%, list=31%, signal=61%</td></tr><tr><td class='lessen'>827</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td><td></td><td>30</td><td>-0.23</td><td>-0.77</td><td>0.736</td><td>0.878</td><td>1.000</td><td>2280</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>828</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td><td></td><td>22</td><td>-0.28</td><td>-0.76</td><td>0.787</td><td>0.881</td><td>1.000</td><td>2851</td><td>tags=45%, list=26%, signal=61%</td></tr><tr><td class='lessen'>829</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN</td><td></td><td>28</td><td>-0.24</td><td>-0.76</td><td>0.727</td><td>0.880</td><td>1.000</td><td>2646</td><td>tags=39%, list=24%, signal=52%</td></tr><tr><td class='lessen'>830</td><td>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</td><td></td><td>35</td><td>-0.21</td><td>-0.76</td><td>0.769</td><td>0.879</td><td>1.000</td><td>1913</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>831</td><td>WOO_LIVER_CANCER_RECURRENCE_UP</td><td></td><td>65</td><td>-0.20</td><td>-0.76</td><td>0.759</td><td>0.878</td><td>1.000</td><td>2440</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>832</td><td>HASLINGER_B_CLL_WITH_11Q23_DELETION</td><td></td><td>16</td><td>-0.27</td><td>-0.76</td><td>0.733</td><td>0.878</td><td>1.000</td><td>2534</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>833</td><td>ZIRN_TRETINOIN_RESPONSE_WT1_UP</td><td></td><td>15</td><td>-0.30</td><td>-0.76</td><td>0.733</td><td>0.878</td><td>1.000</td><td>2384</td><td>tags=47%, list=22%, signal=60%</td></tr><tr><td class='lessen'>834</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>86</td><td>-0.19</td><td>-0.76</td><td>0.849</td><td>0.877</td><td>1.000</td><td>2253</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>835</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td><td></td><td>48</td><td>-0.22</td><td>-0.76</td><td>0.860</td><td>0.877</td><td>1.000</td><td>2155</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>836</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION</td><td></td><td>46</td><td>-0.22</td><td>-0.76</td><td>0.891</td><td>0.876</td><td>1.000</td><td>1357</td><td>tags=17%, list=12%, signal=20%</td></tr><tr><td class='lessen'>837</td><td>OHM_METHYLATED_IN_ADULT_CANCERS</td><td></td><td>20</td><td>-0.24</td><td>-0.76</td><td>0.774</td><td>0.876</td><td>1.000</td><td>2384</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>838</td><td>MCCLUNG_COCAINE_REWARD_5D</td><td></td><td>46</td><td>-0.20</td><td>-0.76</td><td>0.847</td><td>0.875</td><td>1.000</td><td>2051</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>839</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>203</td><td>-0.19</td><td>-0.76</td><td>0.788</td><td>0.874</td><td>1.000</td><td>1646</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>840</td><td>SCHUHMACHER_MYC_TARGETS_UP</td><td></td><td>36</td><td>-0.24</td><td>-0.76</td><td>0.724</td><td>0.876</td><td>1.000</td><td>790</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>841</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP</td><td></td><td>21</td><td>-0.25</td><td>-0.76</td><td>0.821</td><td>0.876</td><td>1.000</td><td>1196</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>842</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</td><td></td><td>47</td><td>-0.19</td><td>-0.76</td><td>0.870</td><td>0.875</td><td>1.000</td><td>3179</td><td>tags=38%, list=29%, signal=54%</td></tr><tr><td class='lessen'>843</td><td>WEIGEL_OXIDATIVE_STRESS_RESPONSE</td><td></td><td>21</td><td>-0.26</td><td>-0.76</td><td>0.909</td><td>0.876</td><td>1.000</td><td>2117</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>844</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5</td><td></td><td>50</td><td>-0.21</td><td>-0.76</td><td>0.843</td><td>0.875</td><td>1.000</td><td>1001</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>845</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</td><td></td><td>25</td><td>-0.24</td><td>-0.76</td><td>0.842</td><td>0.875</td><td>1.000</td><td>2165</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>846</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>265</td><td>-0.20</td><td>-0.76</td><td>0.765</td><td>0.875</td><td>1.000</td><td>1780</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>847</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_UP</td><td></td><td>21</td><td>-0.25</td><td>-0.75</td><td>0.786</td><td>0.885</td><td>1.000</td><td>2386</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>848</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>83</td><td>-0.21</td><td>-0.75</td><td>0.810</td><td>0.885</td><td>1.000</td><td>2378</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>849</td><td>GHANDHI_DIRECT_IRRADIATION_UP</td><td></td><td>55</td><td>-0.23</td><td>-0.74</td><td>0.755</td><td>0.889</td><td>1.000</td><td>2195</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>850</td><td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td><td></td><td>44</td><td>-0.23</td><td>-0.74</td><td>0.739</td><td>0.889</td><td>1.000</td><td>1803</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>851</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td><td></td><td>46</td><td>-0.21</td><td>-0.74</td><td>0.880</td><td>0.891</td><td>1.000</td><td>1931</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>852</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7</td><td></td><td>41</td><td>-0.23</td><td>-0.74</td><td>0.850</td><td>0.894</td><td>1.000</td><td>2478</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>853</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_DN</td><td></td><td>52</td><td>-0.18</td><td>-0.74</td><td>0.927</td><td>0.893</td><td>1.000</td><td>3035</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>854</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN</td><td></td><td>24</td><td>-0.23</td><td>-0.74</td><td>0.818</td><td>0.893</td><td>1.000</td><td>2148</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>855</td><td>MARTENS_TRETINOIN_RESPONSE_DN</td><td></td><td>327</td><td>-0.17</td><td>-0.73</td><td>0.833</td><td>0.904</td><td>1.000</td><td>1960</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>856</td><td>TONG_INTERACT_WITH_PTTG1</td><td></td><td>24</td><td>-0.23</td><td>-0.72</td><td>0.843</td><td>0.905</td><td>1.000</td><td>2673</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>857</td><td>MAYBURD_RESPONSE_TO_L663536_DN</td><td></td><td>31</td><td>-0.27</td><td>-0.72</td><td>0.818</td><td>0.906</td><td>1.000</td><td>933</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>858</td><td>BEIER_GLIOMA_STEM_CELL_UP</td><td></td><td>16</td><td>-0.24</td><td>-0.71</td><td>0.843</td><td>0.918</td><td>1.000</td><td>2934</td><td>tags=31%, list=27%, signal=43%</td></tr><tr><td class='lessen'>859</td><td>NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON</td><td></td><td>28</td><td>-0.22</td><td>-0.71</td><td>0.814</td><td>0.919</td><td>1.000</td><td>2965</td><td>tags=39%, list=27%, signal=54%</td></tr><tr><td class='lessen'>860</td><td>HILLION_HMGA1B_TARGETS</td><td></td><td>58</td><td>-0.18</td><td>-0.71</td><td>0.849</td><td>0.922</td><td>1.000</td><td>1759</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>861</td><td>WANG_RESPONSE_TO_BEXAROTENE_UP</td><td></td><td>19</td><td>-0.22</td><td>-0.71</td><td>0.792</td><td>0.921</td><td>1.000</td><td>3110</td><td>tags=37%, list=29%, signal=51%</td></tr><tr><td class='lessen'>862</td><td>SU_PLACENTA</td><td></td><td>18</td><td>-0.25</td><td>-0.71</td><td>0.891</td><td>0.920</td><td>1.000</td><td>3245</td><td>tags=44%, list=30%, signal=63%</td></tr><tr><td class='lessen'>863</td><td>BENPORATH_PRC2_TARGETS</td><td></td><td>354</td><td>-0.18</td><td>-0.71</td><td>0.905</td><td>0.920</td><td>1.000</td><td>2073</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>864</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP</td><td></td><td>23</td><td>-0.26</td><td>-0.70</td><td>0.821</td><td>0.922</td><td>1.000</td><td>2370</td><td>tags=39%, list=22%, signal=50%</td></tr><tr><td class='lessen'>865</td><td>LIU_CDX2_TARGETS_UP</td><td></td><td>17</td><td>-0.25</td><td>-0.70</td><td>0.889</td><td>0.923</td><td>1.000</td><td>3273</td><td>tags=47%, list=30%, signal=67%</td></tr><tr><td class='lessen'>866</td><td>CHEN_LUNG_CANCER_SURVIVAL</td><td></td><td>15</td><td>-0.27</td><td>-0.70</td><td>0.800</td><td>0.925</td><td>1.000</td><td>2837</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>867</td><td>MOOTHA_HUMAN_MITODB_6_2002</td><td></td><td>250</td><td>-0.18</td><td>-0.70</td><td>0.763</td><td>0.927</td><td>1.000</td><td>2076</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>868</td><td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</td><td></td><td>15</td><td>-0.27</td><td>-0.69</td><td>0.851</td><td>0.931</td><td>1.000</td><td>1362</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>869</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td><td></td><td>69</td><td>-0.19</td><td>-0.69</td><td>0.891</td><td>0.931</td><td>1.000</td><td>2241</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>870</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN</td><td></td><td>35</td><td>-0.22</td><td>-0.69</td><td>0.840</td><td>0.934</td><td>1.000</td><td>1721</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>871</td><td>CHANDRAN_METASTASIS_TOP50_DN</td><td></td><td>28</td><td>-0.25</td><td>-0.68</td><td>0.857</td><td>0.934</td><td>1.000</td><td>3378</td><td>tags=46%, list=31%, signal=67%</td></tr><tr><td class='lessen'>872</td><td>BROWNE_HCMV_INFECTION_30MIN_DN</td><td></td><td>82</td><td>-0.17</td><td>-0.68</td><td>1.000</td><td>0.940</td><td>1.000</td><td>2959</td><td>tags=30%, list=27%, signal=42%</td></tr><tr><td class='lessen'>873</td><td>AMIT_EGF_RESPONSE_60_MCF10A</td><td></td><td>18</td><td>-0.26</td><td>-0.67</td><td>0.774</td><td>0.947</td><td>1.000</td><td>2851</td><td>tags=39%, list=26%, signal=53%</td></tr><tr><td class='lessen'>874</td><td>NUTT_GBM_VS_AO_GLIOMA_DN</td><td></td><td>21</td><td>-0.26</td><td>-0.67</td><td>0.846</td><td>0.947</td><td>1.000</td><td>3084</td><td>tags=38%, list=28%, signal=53%</td></tr><tr><td class='lessen'>875</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_DN</td><td></td><td>27</td><td>-0.20</td><td>-0.66</td><td>0.918</td><td>0.949</td><td>1.000</td><td>1336</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>876</td><td>AMIT_EGF_RESPONSE_120_MCF10A</td><td></td><td>24</td><td>-0.21</td><td>-0.66</td><td>0.941</td><td>0.948</td><td>1.000</td><td>1438</td><td>tags=21%, list=13%, signal=24%</td></tr><tr><td class='lessen'>877</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP</td><td></td><td>28</td><td>-0.20</td><td>-0.66</td><td>0.981</td><td>0.948</td><td>1.000</td><td>2142</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>878</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1</td><td></td><td>20</td><td>-0.25</td><td>-0.66</td><td>0.909</td><td>0.950</td><td>1.000</td><td>138</td><td>tags=10%, list=1%, signal=10%</td></tr><tr><td class='lessen'>879</td><td>GRABARCZYK_BCL11B_TARGETS_UP</td><td></td><td>27</td><td>-0.20</td><td>-0.66</td><td>0.933</td><td>0.950</td><td>1.000</td><td>1720</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>880</td><td>MCCABE_HOXC6_TARGETS_CANCER_UP</td><td></td><td>17</td><td>-0.25</td><td>-0.65</td><td>0.939</td><td>0.955</td><td>1.000</td><td>2731</td><td>tags=35%, list=25%, signal=47%</td></tr><tr><td class='lessen'>881</td><td>ZHENG_IL22_SIGNALING_UP</td><td></td><td>26</td><td>-0.22</td><td>-0.65</td><td>0.906</td><td>0.956</td><td>1.000</td><td>1538</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>882</td><td>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</td><td></td><td>19</td><td>-0.21</td><td>-0.64</td><td>0.917</td><td>0.955</td><td>1.000</td><td>1930</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>883</td><td>MOOTHA_GLYCOLYSIS</td><td></td><td>15</td><td>-0.26</td><td>-0.64</td><td>0.814</td><td>0.957</td><td>1.000</td><td>2871</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>884</td><td>MANTOVANI_NFKB_TARGETS_UP</td><td></td><td>27</td><td>-0.21</td><td>-0.64</td><td>0.933</td><td>0.957</td><td>1.000</td><td>1679</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>885</td><td>MARSON_FOXP3_TARGETS_DN</td><td></td><td>26</td><td>-0.21</td><td>-0.64</td><td>0.889</td><td>0.956</td><td>1.000</td><td>2250</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>886</td><td>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>32</td><td>-0.20</td><td>-0.64</td><td>0.953</td><td>0.957</td><td>1.000</td><td>3002</td><td>tags=34%, list=28%, signal=47%</td></tr><tr><td class='lessen'>887</td><td>KORKOLA_EMBRYONAL_CARCINOMA_UP</td><td></td><td>20</td><td>-0.24</td><td>-0.63</td><td>0.912</td><td>0.959</td><td>1.000</td><td>216</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>888</td><td>GROSS_ELK3_TARGETS_DN</td><td></td><td>17</td><td>-0.23</td><td>-0.63</td><td>0.944</td><td>0.958</td><td>1.000</td><td>858</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>889</td><td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td><td></td><td>34</td><td>-0.23</td><td>-0.63</td><td>0.864</td><td>0.958</td><td>1.000</td><td>2679</td><td>tags=35%, list=25%, signal=47%</td></tr><tr><td class='lessen'>890</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_DN</td><td></td><td>100</td><td>-0.15</td><td>-0.63</td><td>0.979</td><td>0.957</td><td>1.000</td><td>2500</td><td>tags=22%, list=23%, signal=28%</td></tr><tr><td class='lessen'>891</td><td>HOSHIDA_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>43</td><td>-0.18</td><td>-0.63</td><td>0.911</td><td>0.956</td><td>1.000</td><td>2521</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>892</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td><td></td><td>16</td><td>-0.25</td><td>-0.63</td><td>0.906</td><td>0.957</td><td>1.000</td><td>1161</td><td>tags=13%, list=11%, signal=14%</td></tr><tr><td class='lessen'>893</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</td><td></td><td>28</td><td>-0.20</td><td>-0.62</td><td>0.941</td><td>0.960</td><td>1.000</td><td>1313</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>894</td><td>YOKOE_CANCER_TESTIS_ANTIGENS</td><td></td><td>18</td><td>-0.22</td><td>-0.62</td><td>0.958</td><td>0.960</td><td>1.000</td><td>3057</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>895</td><td>ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>26</td><td>-0.19</td><td>-0.61</td><td>0.958</td><td>0.964</td><td>1.000</td><td>1168</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>896</td><td>WONG_MITOCHONDRIA_GENE_MODULE</td><td></td><td>119</td><td>-0.18</td><td>-0.61</td><td>0.893</td><td>0.963</td><td>1.000</td><td>2938</td><td>tags=30%, list=27%, signal=41%</td></tr><tr><td class='lessen'>897</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP</td><td></td><td>19</td><td>-0.21</td><td>-0.60</td><td>0.938</td><td>0.967</td><td>1.000</td><td>2309</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>898</td><td>CUI_TCF21_TARGETS_DN</td><td></td><td>17</td><td>-0.21</td><td>-0.59</td><td>1.000</td><td>0.970</td><td>1.000</td><td>2870</td><td>tags=35%, list=26%, signal=48%</td></tr><tr><td class='lessen'>899</td><td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td><td></td><td>21</td><td>-0.21</td><td>-0.59</td><td>1.000</td><td>0.970</td><td>1.000</td><td>2620</td><td>tags=38%, list=24%, signal=50%</td></tr><tr><td class='lessen'>900</td><td>CHO_NR4A1_TARGETS</td><td></td><td>23</td><td>-0.20</td><td>-0.58</td><td>0.926</td><td>0.973</td><td>1.000</td><td>1507</td><td>tags=17%, list=14%, signal=20%</td></tr><tr><td class='lessen'>901</td><td>LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES</td><td></td><td>17</td><td>-0.19</td><td>-0.58</td><td>0.962</td><td>0.973</td><td>1.000</td><td>2165</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>902</td><td>NAGASHIMA_EGF_SIGNALING_UP</td><td></td><td>25</td><td>-0.27</td><td>-0.57</td><td>0.942</td><td>0.974</td><td>1.000</td><td>2245</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>903</td><td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td><td></td><td>20</td><td>-0.18</td><td>-0.56</td><td>0.980</td><td>0.978</td><td>1.000</td><td>986</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>904</td><td>RICKMAN_HEAD_AND_NECK_CANCER_D</td><td></td><td>15</td><td>-0.20</td><td>-0.56</td><td>0.945</td><td>0.978</td><td>1.000</td><td>2049</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>905</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6</td><td></td><td>16</td><td>-0.18</td><td>-0.55</td><td>1.000</td><td>0.978</td><td>1.000</td><td>2179</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>906</td><td>SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>41</td><td>-0.17</td><td>-0.53</td><td>0.962</td><td>0.985</td><td>1.000</td><td>2729</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>907</td><td>VANTVEER_BREAST_CANCER_BRCA1_DN</td><td></td><td>21</td><td>-0.16</td><td>-0.49</td><td>0.959</td><td>0.990</td><td>1.000</td><td>3498</td><td>tags=33%, list=32%, signal=49%</td></tr><tr><td class='lessen'>908</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>23</td><td>-0.19</td><td>-0.49</td><td>0.980</td><td>0.990</td><td>1.000</td><td>1709</td><td>tags=17%, list=16%, signal=21%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>EP (11 samples)<b>&nbsp<a href='gsea_report_for_EP_1489395374806.xls'>[plain text format]</a></caption></table></div><br></body></html>